var title_f34_14_35040="Chronic anal fissure";
var content_f34_14_35040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic anal fissure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photograph of a chronic anal fissure in the posterior midline (arrow), which is the most common site of fissure formation. The raised edges and fibrotic appearance at the base of this fissure distinguish it from an acute anal fissure, which appears like a fresh laceration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced by permission from: the American Society of Colon and Rectal Surgeons.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35040=[""].join("\n");
var outline_f34_14_35040=null;
var title_f34_14_35041="Mushroom spore print";
var content_f34_14_35041=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F55358&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F55358&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mushroom spore print",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This mushroom cap was placed upon the paper several hours ago and was kept in a room without significant wind or drafts. The resulting print is highly specific to the genus and species of the mushroom but should be interpreted by a professional mycologist.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Dengler.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35041=[""].join("\n");
var outline_f34_14_35041=null;
var title_f34_14_35042="Marking the erythema associated with a hand infection";
var content_f34_14_35042=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F63361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F63361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Marking the erythema associated with a hand infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This demonstrates erythema following a catfish sting. The area of erythema has been marked to allow assessment of the patient's response to antibiotic therapy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35042=[""].join("\n");
var outline_f34_14_35042=null;
var title_f34_14_35043="Nipple inversion associated with malignancy";
var content_f34_14_35043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F69802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F69802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nipple inversion associated with malignancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 397px; height: 442px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nipple inversion associated with a malignancy tends to be asymmetric and distorts the areola.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35043=[""].join("\n");
var outline_f34_14_35043=null;
var title_f34_14_35044="EP study tracings concealed pathway ventricular pacing";
var content_f34_14_35044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 538px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study showing orthodromic AV reentrant tachycardia utilizing concealed accessory pathway during ventricular pacing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 518px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are three surface ECG leads (I, aVF, and V1) and intracardiac recordings from the high right atrium (HRA), proximal (HBE3-4) and distal His bundle region (HBE1-2), proximal to distal coronary sinus (CS9-10, CS7-8, CS5-6, CS3-4, and CS1-2), right ventricular apex (RVA3-4), from a mapping catheter's distal (USER1) and proximal (USER3) electrode pairs, and a stimulus artifact (S) channel (STIM). The mapping catheter was advanced through the right femoral artery and retrograde across the aortic valve into the left ventricle. With each ventricular paced beat (V) there is retrograde conduction from the ventricle to atrium (A) via the left free wall accessory pathway. The mapping catheter has been maneuvered to the site along the mitral annulus which records the earliest atrial activity (red arrow); the atrial activity recorded at the tip electrode of USER1 precedes the earliest atrial activity (black arrow) noted in the coronary sinus (CS1-2) by 25 msec.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35044=[""].join("\n");
var outline_f34_14_35044=null;
var title_f34_14_35045="Progesterone: Patient drug information";
var content_f34_14_35045=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Progesterone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/59/6072?source=see_link\">",
"     see \"Progesterone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F213986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Crinone&reg;;",
"     </li>",
"     <li>",
"      Endometrin&reg;;",
"     </li>",
"     <li>",
"      First&trade;-Progesterone VGS 100;",
"     </li>",
"     <li>",
"      First&trade;-Progesterone VGS 200;",
"     </li>",
"     <li>",
"      First&trade;-Progesterone VGS 25;",
"     </li>",
"     <li>",
"      First&trade;-Progesterone VGS 400;",
"     </li>",
"     <li>",
"      First&trade;-Progesterone VGS 50;",
"     </li>",
"     <li>",
"      Prometrium&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F213987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Crinone&reg;;",
"     </li>",
"     <li>",
"      Prometrium&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700305",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take with estrogens to stop heart disease or dementia. Using estrogens may raise your chances of having a heart attack, a stroke, breast cancer, or a blood clot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used in",
"       <i>",
"        in vitro",
"       </i>",
"       fertilization.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop endometrial changes in women after change of life who are getting estrogen therapy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691686",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat uterine bleeding due to hormonal imbalance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691832",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat endometriosis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691842",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat women who do not have a monthly period cycle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702801",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to progesterone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701376",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a peanut allergy and are taking the capsules. The capsules have peanut oil in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703339",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bleeding into the brain, blood clots, breast cancer, heart attack, liver disease, stroke, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Capsule:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701537",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to any type of nuts or seeds, talk with your doctor. Some products have nuts in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort with this drug. This drug may not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696898",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take other vaginal drugs within 6 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698553",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Periodic breast (monthly self-exam) and regular breast and gynecologic exams are major.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697924",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Breast pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, period changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Capsule:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694870",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use as you have been told by your doctor or read the package insert.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705579",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Vaginal:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696174",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use gel vaginally.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696204",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use tablet vaginally.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10995 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-219.243.220.100-C38B34FA94-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35045=[""].join("\n");
var outline_f34_14_35045=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213986\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F213987\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025178\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025180\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025179\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025184\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025185\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025187\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025182\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025183\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025188\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025189\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?5/59/6072?source=related_link\">",
"      Progesterone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_14_35046="Suction curettage molar pregnan";
var content_f34_14_35046=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57978&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57978&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Suction curettage of molar pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 355px; height: 660px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35046=[""].join("\n");
var outline_f34_14_35046=null;
var title_f34_14_35047="Low gradient aortic stenosis";
var content_f34_14_35047=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Low gradient aortic stenosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35047/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35047/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35047/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35047/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35047/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35047/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/14/35047/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic patients with severe aortic stenosis (AS) generally have a substantial improvement in symptoms and increased survival after aortic valve replacement. These beneficial results can even be observed in those who have developed left ventricular (LV) dysfunction and heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, not all such patients benefit from aortic valve replacement. In particular, the subset of patients with AS and a low transvalvular pressure gradient due to significant LV failure have considerable operative risk and limited potential for improvement with surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues relating to low gradient AS will be reviewed here. The clinical presentation and treatment of AS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21706?source=see_link\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/8/31881?source=see_link&amp;anchor=H10#H10\">",
"     \"Indications for valve replacement in aortic stenosis in adults\", section on 'Low gradient aortic stenosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/62/2025?source=see_link\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION AND SPECTRUM OF DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The transaortic gradient depends upon the severity of the stenosis and upon flow rate, which is determined by the stroke volume and systolic ejection period. Most patients with symptomatic severe AS have a valve area that is &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a mean transvalvular pressure gradient that exceeds 40 mmHg (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"mobipreview.htm?17/33/17948\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Low gradient AS is defined as severe AS (valve area &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    ) with a transvalvular pressure gradient of less than 30 mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/4\">",
"     4",
"    </a>",
"    ]. Low gradient AS occurs in the setting of a low flow rate across the valve. Low gradient AS is seen in patients with left ventricular (LV) systolic dysfunction with reduced left ventricular ejection fraction (LVEF) but it also occurs in patients with normal LVEF.",
"   </p>",
"   <p>",
"    The overall morbidity and mortality of such patients with aortic surgery is considerable, since approximately one-half either do not survive or continue to have persistent symptoms postoperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. In one series of over 600 patients with AS, those with a peak-to-peak systolic pressure gradient &gt;125 mmHg had the best postoperative survival, while those with a gradient &lt;35 mmHg had the worst [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/6\">",
"     6",
"    </a>",
"    ]. The risk is increased further in patients who also have coronary artery disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A challenging clinical task is distinguishing patients with low gradient AS who will survive and improve after aortic valve replacement surgery from those who will not. There is a subset of patients with AS and low transvalvular gradients who do not benefit from aortic valve replacement and are at considerable risk of operative death. These patients have a significant degree of left ventricular dysfunction but only mild to moderate AS. They are considered to have \"pseudostenosis\" because their symptoms are primarily due to poor LV function, not significant valvular disease. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Pseudostenosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Left ventricular dysfunction in patients with AS is referred to as",
"    <strong>",
"     primary",
"    </strong>",
"    if decreased function is caused primarily by factors other than a stenotic aortic valve and as",
"    <strong>",
"     secondary",
"    </strong>",
"    if decreased function results directly from the valvular lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22874573\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with low gradient AS are identified by echocardiography. While",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    echocardiography alone may be of some value, complete evaluation may require cardiac catheterization with precise measurement of pressure and flow at baseline and during a dobutamine infusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines concluded that the weight of",
"    <span class=\"nowrap\">",
"     evidence/opinion",
"    </span>",
"    was in favor of the efficacy of both dobutamine echocardiography and cardiac catheterization with a dobutamine infusion for the evaluation of low gradient AS and left ventricular dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15019940\">",
"    <span class=\"h2\">",
"     Reduced LVEF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with reduced left ventricular ejection fraction (LVEF) and severe AS have reduced transvalvular flow rates and thus relatively low aortic transvalvular gradients. Among patients with AS with reduced LVEF, patients with true stenosis should be distinguished from those with pseudostenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     True stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe AS and secondary LV dysfunction that leads to a low transvalvular pressure gradient are considered to have \"true stenosis.\" In this setting, the severe stenotic lesion results in excessive afterload and a reduced LVEF, thereby producing both a markedly decreased stroke volume and low transvalvular pressure gradient. It is logical to assume that aortic valve replacement will be beneficial in these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Pseudostenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In pseudostenosis, patients have a low transvalvular pressure gradient because of the combination of moderate AS and low cardiac output. The low output reduces the valve opening forces, resulting in limited mobility of a valve that is not severely diseased. The calculated valve area may mistakenly suggest severe stenosis because of valve area equation limitations when applied to low flow rate conditions. In contrast to true stenosis, surgical correction in these patients is unlikely to be beneficial.",
"   </p>",
"   <p>",
"    The standard Gorlin equation for aortic valve area tends to underestimate the valve area when cardiac output is low. As a result, this formula has limited utility for distinguishing pseudostenosis (a flow-dependent phenomenon) from true severe AS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/11/1208?source=see_link&amp;anchor=H3#H3\">",
"     \"Aortic valve area in aortic stenosis\", section on 'Gorlin equation for aortic valve area'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The calculated orifice area is strongly dependent upon the flow rate for two reasons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Discharge coefficients (constants) for the calculation have not been precisely defined",
"     </li>",
"     <li>",
"      The failing ventricle generates inadequate valve opening forces.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Gorlin equation predicts that at low transvalvular flows (less than 175",
"    <span class=\"nowrap\">",
"     mL/sec),",
"    </span>",
"    the mean transvalvular gradient will be less than 20 mmHg independent of aortic valve area, suggesting only mild AS (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"mobipreview.htm?17/33/17948\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since hemodynamic resistance is affected less by flow rate than by valve area, the valve resistance can be used to supplement valve area calculations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/15\">",
"     15",
"    </a>",
"    ]. However, pharmacologic stimulation is often required to establish the diagnosis with confidence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15019850\">",
"    <span class=\"h2\">",
"     Normal LVEF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although low gradient AS often occurs in patients with a reduced LVEF, it can also be seen in patients with a normal LVEF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/16\">",
"     16",
"    </a>",
"    ]. This entity has been called &ldquo;paradoxical low-flow, low gradient AS&rdquo;. This condition is most often seen in patients with concentric left ventricular hypertrophy who should be distinguished from those without concentric left ventricular hypertrophy since the latter may have a more benign prognosis.",
"   </p>",
"   <p>",
"    Patients with low gradient AS with concentric left ventricular hypertrophy and a normal LVEF have worse outcomes compared to those with higher gradients. In a study of 512 consecutive patients with severe AS (aortic valve area index &le;0.6",
"    <span class=\"nowrap\">",
"     cm",
"     <sup>",
"      2",
"     </sup>",
"     /m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    and a normal LVEF (&ge;50 percent), the 181 (35 percent) with low flow (stroke volume index &le;35",
"    <span class=\"nowrap\">",
"     mL/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    had a significantly lower overall three-year survival compared to the 331 (65 percent) patients with a normal flow rate (76 versus 86 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/16\">",
"     16",
"    </a>",
"    ]. Mean left ventricular mass and relative wall thickness were elevated consistent with concentric left ventricular hypertrophy, and stroke volume was small, which results in a relatively low pressure gradient. In those circumstances careful attention should be paid to accurate valve area calculations. Symptom status was not reported in this study, but outcomes in both groups were better with surgical compared to medical therapy.",
"   </p>",
"   <p>",
"    The prognosis may be better in patients with low gradient AS with normal left ventricular function",
"    <strong>",
"     without",
"    </strong>",
"    left ventricular hypertrophy. A prospective study of asymptomatic patients with normal LVEF (&ge;55 percent) from the SEAS cohort found that the 435 with severe low gradient AS (aortic valve area &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    ; mean gradient &le;40 mmHg) had an event-free survival similar to that in patients with moderate AS (aortic valve area 1.0 to 1.5 cm",
"    <sup>",
"     2",
"    </sup>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/17\">",
"     17",
"    </a>",
"    ]. Mean left ventricular mass was normal in patients with low gradient severe AS (98.9",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    and lower than in those with moderate stenosis (mean 108.9",
"    <span class=\"nowrap\">",
"     g/m",
"     <sup>",
"      2",
"     </sup>",
"     ).",
"    </span>",
"    The mean relative wall thickness was normal in both groups (36.5 and 37.3). During 46-months follow-up, similar rates of aortic valve events (48.5 and 44.6 percent) and cardiovascular death (7.8 versus 4.9 percent, p = 0.19) were observed. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIFFERENTIATING TRUE STENOSIS FROM PSEUDOSTENOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability to distinguish between true stenosis and pseudostenosis relies upon characteristic changes in hemodynamic and structural measurements in response to augmented cardiac output. The principal pharmacologic interventions involve the administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Dobutamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with pseudostenosis manifest an increase in the calculated aortic valve area and a decrease in valve resistance in response to an elevation in cardiac output induced by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    infusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/14,18-20\">",
"     14,18-20",
"    </a>",
"    ]. The response differs in patients with severe true AS in whom a dobutamine-induced increase in transvalvular flow will produce an increase in the mean transvalvular gradient but no change in aortic valve area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Various responses to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress were illustrated in an echocardiographic study of 18 patients with low gradient AS; intravenous dobutamine was started at 5",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per min and gradually increased to a maximal dose of 20",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per min [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Five patients with pseudostenosis exhibited both a significant increase in aortic valve area (0.8 to 1.1 cm",
"      <sup>",
"       2",
"      </sup>",
"      ) and a decline in valve resistance with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      . Four of the five were treated medically and were alive at one year; the fifth patient died as a result of severe coronary disease.",
"     </li>",
"     <li>",
"      By comparison, all seven patients with true stenosis showed no change in valve area and an increase in valve resistance; severe AS was confirmed at the time of surgery in four of these patients.",
"     </li>",
"     <li>",
"      In the remaining six patients, LV contractile reserve was inadequate and the results were indeterminate. Such patients have a poor prognosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Predictors of outcome from surgery'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A subsequent study in which",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    challenge was performed during cardiac catheterization suggested that use of the valve area calculation alone often leads to misclassification, and that the mean valve gradient in response to dobutamine is also important [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/10\">",
"     10",
"    </a>",
"    ]. In this report, all 20 patients with a final aortic valve area &le;1.2 cm",
"    <sup>",
"     2",
"    </sup>",
"    and a mean gradient above 30 mmHg at peak dobutamine infusion had severe AS at surgery. Eight of these patients had an increase in valve area &ge;0.3 cm",
"    <sup>",
"     2",
"    </sup>",
"    during dobutamine infusion, incorrectly suggesting pseudostenosis. In addition, one patient had a final aortic valve area &le;1.2 cm",
"    <sup>",
"     2",
"    </sup>",
"    but a mean gradient below 30 mmHg during dobutamine; this patient had mild AS at surgery. Thus, both the valve area and mean gradient responses are important.",
"   </p>",
"   <p>",
"    The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on the management of patients with valvular heart disease (this section not changed by the 2008 focused update) concluded that it is likely that baseline calculations overestimated the severity of AS if a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    infusion produces an increment in stroke volume, an increase in valve area, and little change in gradient (decrease in valve resistance) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/4\">",
"     4",
"    </a>",
"    ]. In patients with pseudostenosis, the calculated valve area during dobutamine infusion will fall outside the severe range, suggesting the absence of severe disease.",
"   </p>",
"   <p>",
"    One limitation of stress echocardiography for evaluation of the severity of low gradient AS is a variable increase in stroke volume in response to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    . Standardization based upon indexing the increase in valve area to the transvalvular flow rate has been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/21\">",
"     21",
"    </a>",
"    ]. In a series of 23 adults, this approach distinguished true stenosis from pseudostenosis, using surgical inspection as the reference standard, with an accuracy of 83 percent compared to an accuracy of 61 percent with other measures of stenosis severity. This approach requires more complex measurements and calculations and further validation is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Plasma brain natriuretic peptide",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability of plasma brain natriuretic peptide (BNP) to separate patients with true stenosis from those with pseudostenosis was evaluated in 69 patients with low mean gradient (&le;40 mmHg) and low flow (indexed aortic orifice area",
"    <span class=\"nowrap\">",
"     &lt;0.6cm",
"     <sup>",
"      2",
"     </sup>",
"     /m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    AS with reduced left ventricular ejection fraction (&le;40 percent) enrolled in the TOPAS study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/22\">",
"     22",
"    </a>",
"    ]. After classification using",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography, patients with true AS (20) compared to those with pseudostenosis (40) had significantly higher BNP levels (median, 743 versus 471",
"    <span class=\"nowrap\">",
"     pg/mL).",
"    </span>",
"    However, further studies are needed because BNP may be elevated due to LV dysfunction with heart failure, even when AS is not severe.",
"   </p>",
"   <p>",
"    The use of plasma BNP to predict outcome from surgery is presented below and an overview of the use of plasma BNP as a tool for diagnosis and management of cardiovascular disease is discussed separately. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Plasma BNP'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19818?source=see_link\">",
"     \"Natriuretic peptide measurement in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15020014\">",
"    <span class=\"h2\">",
"     Mitral annular plane systolic excursion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A preliminary report suggested that mitral annular plane systolic excursion (MAPSE) or displacement (calculated as the mean of septal and lateral systolic mitral annular motion using M-mode echocardiography in an apical four chamber view) may be helpful in distinguishing true stenosis from pseudostenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/23\">",
"     23",
"    </a>",
"    ]. In a population of patients with at least moderate AS and mean transvalvular gradient &lt;40 mmHg, all 20 patients with MAPSE &lt;9 mm had severe aortic stenosis and all 17 of those with displacements &ge;9 mm had moderate aortic stenosis. MAPSE was inversely correlated with interstitial fibrosis on myocardial biopsy. As noted below, MAPSE may also predict functional improvement in patients with severe AS who undergo valve replacement. (See",
"    <a class=\"local\" href=\"#H15020034\">",
"     'MAPSE'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;In summary, patients with pseudostenosis have in the basal state a calculated effective aortic valve area that is less than 1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    , a low transvalvular pressure gradient (often less than 25 mmHg) and low valve resistance (often less than 200 dsc). The administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    in such patients typically produces an increase in the valve area and a decrease in resistance. Although these data are derived from relatively small studies with limited clinical and follow-up information, the distinction is important because there is little potential for improvement with aortic valve replacement. Further studies are needed to confirm the value of BNP and mitral ring displacement in distinguishing pseudostenosis from true stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PREDICTORS OF OUTCOME FROM SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although aortic valve replacement is recommended for patients with true AS and a low gradient, the surgical mortality is high, and the risk is increased further in those who also have coronary artery disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/5,7,8\">",
"     5,7,8",
"    </a>",
"    ]. In a report of 52 patients with an LVEF &le;35 percent (mean 26 percent) and a transvalvular mean gradient of &lt;30 mmHg (mean 23 mmHg), the perioperative (30 day) mortality was 21 percent, and overall survival at three and five years was 62 and 39 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/8\">",
"     8",
"    </a>",
"    ]. Survival at five years was much lower in patients with coronary artery disease (29 versus 71 percent). However, among the 30-day survivors, there were significant improvements in functional status and LVEF.",
"   </p>",
"   <p>",
"    Surgery is still recommended in most patients with low gradient AS because valve replacement is associated with better outcomes than continued medical therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9,24\">",
"     9,24",
"    </a>",
"    ]. This was illustrated in a study of 95 patients who did or did not undergo aortic valve replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/24\">",
"     24",
"    </a>",
"    ]. Using propensity analysis, patients who underwent valve replacement had a significantly greater survival at one (82 versus 41 percent without surgery) and four years (78 versus 15 percent). The main predictor of improved survival was aortic valve replacement. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/8/31881?source=see_link\">",
"     \"Indications for valve replacement in aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Contractile reserve",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no clinical or hemodynamic variables that are helpful to stratify risk in such patients. However, in addition to its role in distinguishing between true stenosis and pseudostenosis, low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    echocardiography is helpful in risk stratifying patients with severe true AS and in determining the appropriate therapy. Patients with contractile reserve have a much better outcome after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The utility of this approach was best illustrated in a study of 136 patients with symptomatic, severe AS (valve area &le;1 cm",
"    <sup>",
"     2",
"    </sup>",
"    ), a low cardiac index (&le;3.0",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    per m",
"    <sup>",
"     2",
"    </sup>",
"    ), and a mean transvalvular gradient &le;40 mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9\">",
"     9",
"    </a>",
"    ]. Patients with more than mild aortic or mitral regurgitation, atrial fibrillation, or severe comorbidities were excluded.",
"   </p>",
"   <p>",
"    Contractile reserve (defined as an increase in stroke volume of &ge;20 percent above baseline) was demonstrated by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    infusion in 92 patients (68 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9\">",
"     9",
"    </a>",
"    ]. Aortic valve replacement was performed in 95 patients, including 64 with contractile reserve and 31 without. The following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among the patients who underwent valve replacement, those who demonstrated contractile reserve had a lower perioperative mortality (5 versus 32 percent).",
"     </li>",
"     <li>",
"      The 64 patients with contractile reserve undergoing aortic valve replacement had a significantly lower three year mortality rate than those who were managed medically (21 versus 79 percent).",
"     </li>",
"     <li>",
"      The 31 patients without contractile reserve who underwent valve replacement did not have a significant reduction in three year mortality compared to medical therapy (62 versus 89 percent). However, this trend toward lower mortality with surgery might have become significant with a larger number of patients.",
"     </li>",
"     <li>",
"      In a later report of 66 patients survivors of aortic valve replacement from the same multicenter study, the mean improvement in LVEF (19 versus 17 percent), the frequency of improvement of &ge;1 NYHA class (96 versus 90 percent) or &ge;2 NYHA classes (59 versus 55 percent), and the likelihood of being NYHA class I or II (93 versus 85 percent) were similar in those with and without contractile reserve (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"mobipreview.htm?3/2/3117\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/25\">",
"       25",
"      </a>",
"      ]. This observation supports the concept that the absence of contractile reserve alone should not be considered a contraindication to surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/26\">",
"       26",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Summary and recommendations'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The predictive value of contractile reserve on operative mortality was also noted in a study in which",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    challenge was performed in the catheterization laboratory in 32 patients with low output, low gradient AS, an LVEF below 40 percent, and NYHA class III to IV symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/10\">",
"     10",
"    </a>",
"    ]. The criterion for surgery was a final aortic valve area &le;1.2 cm",
"    <sup>",
"     2",
"    </sup>",
"    at peak dobutamine infusion. Eleven patients did not meet this criterion and were treated medically; among the 21 who met the criterion and underwent surgery, contractile reserve (&gt;20 percent increase in stroke volume) was present in 15. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At surgery, 20 of 21 had severe AS; the one patient with mild to moderate disease was the only one with a final mean gradient below 30 mmHg during",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      infusion.",
"     </li>",
"     <li>",
"      The presence of contractile reserve predicted a better outcome from valve replacement. Among the 15 patients with contractile reserve, there was one postoperative death and, at a median follow-up of 32 months, two late noncardiac deaths. Among the six patients with no contractile reserve, there were two postoperative deaths and two late deaths from heart failure.",
"     </li>",
"     <li>",
"      Eleven patients did not undergo surgery, seven of whom were thought not to have severe AS based upon the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      infusion results and four of whom were at too high risk for surgery. At follow-up, seven died of progressive heart failure and one died suddenly.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Plasma BNP",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, plasma brain natriuretic peptide (BNP) has been evaluated as a method of differentiating true AS from pseudostenosis. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Plasma brain natriuretic peptide'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Plasma BNP also correlates with the severity of AS and predicts survival and postoperative outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/27\">",
"     27",
"    </a>",
"    ]. The relationship between plasma BNP and outcome with or without surgery was evaluated in 69 symptomatic (81 percent NYHA functional class II and III) patients with low gradient (&le;40 mmHg), low flow (indexed aortic orifice area",
"    <span class=\"nowrap\">",
"     &lt;0.6cm",
"     <sup>",
"      2",
"     </sup>",
"     /m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    and reduced left ventricular ejection fraction (&le;40 percent) enrolled in the TOPAS study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/22\">",
"     22",
"    </a>",
"    ]. One-year survival was significantly lower in those patients with a plasma BNP &ge;550",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    compared to those with &lt;550",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (47 versus 97 percent) in the entire cohort and in the 29 patients who underwent surgery (53 versus 92 percent).",
"   </p>",
"   <p>",
"    These findings are consistent with previous studies showing that outcome depends upon the severity of LV dysfunction and heart failure. However, plasma BNP will rarely affect clinical decision-making because all of these patients benefit from aortic valve replacement, unless the surgical risk is prohibitive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15020034\">",
"    <span class=\"h2\">",
"     MAPSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, mitral annular plane systolic excursion (MAPSE) may help separate true stenosis from pseudostenosis and mitral ring displacement correlates inversely with myocardial fibrosis. (See",
"    <a class=\"local\" href=\"#H15020014\">",
"     'Mitral annular plane systolic excursion'",
"    </a>",
"    above.) Preliminary studies also found that MAPSE correlated with improvement in New York Heart Association functional class (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"mobipreview.htm?3/2/3117\">",
"     table 2",
"    </a>",
"    ) in patients with severe AS who underwent aortic valve replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/23,28\">",
"     23,28",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/53/36690?source=see_link\">",
"       \"Patient information: Aortic stenosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with low gradient aortic stenosis (AS) are identified by echocardiography.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       Dobutamine",
"      </a>",
"      echocardiography may be helpful in distinguishing true stenosis from pseudostenosis, though some patients require cardiac catheterization with dobutamine infusion for complete evaluation. (See",
"      <a class=\"local\" href=\"#H22874573\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although patients with low gradient AS have considerable operative risks, the available data suggest that those with true stenosis with concentric left ventricular hypertrophy and contractile reserve (defined as &ge;20 percent increase in stroke volume or &gt;10 mmHg increase in the mean transvalvular pressure gradient with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      ) can expect a better outcome than similar patients treated medically [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/4,9,10,26\">",
"       4,9,10,26",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Predictors of outcome from surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with severe true stenosis but without contractile reserve have a significant perioperative mortality risk (32 versus 5 percent in those with contractile reserve in one series) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9\">",
"       9",
"      </a>",
"      ]. However, as noted above, these patients have a similar improvement in LVEF (17 versus 19 percent) and attainment of NYHA class I or II (85 versus 93 percent) as those with contractile reserve [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/25\">",
"       25",
"      </a>",
"      ]. Furthermore, patients without contractile reserve who are treated medically have a very high mortality rate (eg, 89 percent at three years) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Contractile reserve'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Thus, the absence of contractile reserve on",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography is associated with an increased perioperative mortality but should not be considered a contraindication to surgery since the majority of survivors have significant improvements in LVEF and functional class [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35047/abstract/4,26\">",
"       4,26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Proven pseudostenosis is associated with such a high risk (and little potential for improvement) that most clinicians would not proceed with corrective surgery. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pseudostenosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/1\">",
"      Carabello BA, Green LH, Grossman W, et al. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 1980; 62:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/2\">",
"      Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978; 58:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/3\">",
"      Carabello BA. Is it ever too late to operate on the patient with valvular heart disease? J Am Coll Cardiol 2004; 44:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/4\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/5\">",
"      Brogan WC 3rd, Grayburn PA, Lange RA, Hillis LD. Prognosis after valve replacement in patients with severe aortic stenosis and a low transvalvular pressure gradient. J Am Coll Cardiol 1993; 21:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/6\">",
"      Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention. Circulation 1990; 82:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/7\">",
"      Blitz LR, Gorman M, Herrmann HC. Results of aortic valve replacement for aortic stenosis with relatively low transvalvular pressure gradients. Am J Cardiol 1998; 81:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/8\">",
"      Connolly HM, Oh JK, Schaff HV, et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. Circulation 2000; 101:1940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/9\">",
"      Monin JL, Qu&eacute;r&eacute; JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003; 108:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/10\">",
"      Nishimura RA, Grantham JA, Connolly HM, et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 2002; 106:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/11\">",
"      GORLIN R, GORLIN SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J 1951; 41:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/12\">",
"      Cannon SR, Richards KL, Crawford M. Hydraulic estimation of stenotic orifice area: a correction of the Gorlin formula. Circulation 1985; 71:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/13\">",
"      Burwash IG, Thomas DD, Sadahiro M, et al. Dependence of Gorlin formula and continuity equation valve areas on transvalvular volume flow rate in valvular aortic stenosis. Circulation 1994; 89:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/14\">",
"      Grayburn PA. Assessment of low-gradient aortic stenosis with dobutamine. Circulation 2006; 113:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/15\">",
"      Ford LE, Feldman T, Chiu YC, Carroll JD. Hemodynamic resistance as a measure of functional impairment in aortic valvular stenosis. Circ Res 1990; 66:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/16\">",
"      Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007; 115:2856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/17\">",
"      Jander N, Minners J, Holme I, et al. Outcome of patients with low-gradient \"severe\" aortic stenosis and preserved ejection fraction. Circulation 2011; 123:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/18\">",
"      deFilippi CR, Willett DL, Brickner ME, et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995; 75:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/19\">",
"      Bermejo J, Garc&iacute;a-Fern&aacute;ndez MA, Torrecilla EG, et al. Effects of dobutamine on Doppler echocardiographic indexes of aortic stenosis. J Am Coll Cardiol 1996; 28:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/20\">",
"      Lin SS, Roger VL, Pascoe R, et al. Dobutamine stress Doppler hemodynamics in patients with aortic stenosis: feasibility, safety, and surgical correlations. Am Heart J 1998; 136:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/21\">",
"      Blais C, Burwash IG, Mundigler G, et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation 2006; 113:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/22\">",
"      Bergler-Klein J, Mundigler G, Pibarot P, et al. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation 2007; 115:2848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/23\">",
"      Herrmann S, St&ouml;rk S, Niemann M, et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol 2011; 58:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/24\">",
"      Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 2002; 39:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/25\">",
"      Quere JP, Monin JL, Levy F, et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 2006; 113:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/26\">",
"      Lange RA, Hillis LD. Dobutamine stress echocardiography in patients with low-gradient aortic stenosis. Circulation 2006; 113:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/27\">",
"      Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109:2302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35047/abstract/28\">",
"      Weidemann F, Herrmann S, St&ouml;rk S, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009; 120:577.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8114 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-2F5800EE8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35047=[""].join("\n");
var outline_f34_14_35047=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION AND SPECTRUM OF DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22874573\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15019940\">",
"      Reduced LVEF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - True stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Pseudostenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15019850\">",
"      Normal LVEF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIFFERENTIATING TRUE STENOSIS FROM PSEUDOSTENOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Dobutamine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Plasma brain natriuretic peptide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15020014\">",
"      Mitral annular plane systolic excursion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PREDICTORS OF OUTCOME FROM SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Contractile reserve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Plasma BNP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15020034\">",
"      MAPSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8114\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8114|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/33/17948\" title=\"table 1\">",
"      Severity of AS in adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/2/3117\" title=\"table 2\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/11/1208?source=related_link\">",
"      Aortic valve area in aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21706?source=related_link\">",
"      Clinical features and evaluation of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/8/31881?source=related_link\">",
"      Indications for valve replacement in aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/62/2025?source=related_link\">",
"      Medical management of asymptomatic aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19818?source=related_link\">",
"      Natriuretic peptide measurement in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/53/36690?source=related_link\">",
"      Patient information: Aortic stenosis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_14_35048="Constipation in the older adult";
var content_f34_14_35048=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Constipation in the older adult",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35048/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35048/contributors\">",
"     Satish SC Rao, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35048/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35048/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35048/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35048/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/14/35048/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H29212408\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constipation is a common complaint in older adults. It has a major impact on healthcare costs in the United States because it results in several office visits, specialty referrals, hospital admissions, and surgical procedures. It also affects health-related quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the clinical approach to the diagnosis and management of constipation in the older adult. The approach to diagnosis and management of constipation in children and adults in general are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15354?source=see_link\">",
"     \"Constipation in children: Etiology and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/28/36298?source=see_link\">",
"     \"Treatment of chronic functional constipation and fecal incontinence in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link\">",
"     \"Etiology and evaluation of chronic constipation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=see_link\">",
"     \"Management of chronic constipation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212415\">",
"    <span class=\"h1\">",
"     DEFINITION OF CONSTIPATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term constipation is variably defined by patients and physicians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    According to the Rome III criteria, functional constipation is defined as any two of the following features: straining, lumpy hard stools, sensation of incomplete evacuation, use of digital maneuvers, sensation of anorectal obstruction or blockage with 25 percent of bowel movements, and decrease in stool frequency (less than three bowel movements per week). The above criteria must be fulfilled for the last three months with symptom onset six months prior to diagnosis, loose stools should rarely be present without the use of laxatives, and there must be insufficient criteria for a diagnosis of irritable bowel syndrome (IBS).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212422\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of constipation in the older adult has not been well defined. Studies have reported that the prevalence of constipation in the older adult ranges from 24 to 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/3-11\">",
"     3-11",
"    </a>",
"    ]. Laxatives are used daily by 10 and 18 percent of community dwelling older adults and 74 percent of nursing home residents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/8,12-15\">",
"     8,12-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to age, risk factors for chronic constipation include female gender, physical inactivity, low education and income, concurrent medication use, and depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/7,16\">",
"     7,16",
"    </a>",
"    ]. One study showed that older adults who consume fewer calories and meals are also more likely to suffer from constipation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212429\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constipation in the older adult may be due to primary colorectal dysfunction or secondary to several etiologic factors (",
"    <a class=\"graphic graphic_table graphicRef74971 \" href=\"mobipreview.htm?27/10/27819\">",
"     table 1",
"    </a>",
"    ). The etiology of constipation in older patients is often multifactorial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1058372251\">",
"    <span class=\"h2\">",
"     Primary colorectal dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary colorectal dysfunction can be further categorized into three broad subtypes:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212436\">",
"    <span class=\"h3\">",
"     Slow transit constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Slow transit constipation (STC) is characterized by prolonged delay in stool transit throughout the colon. This could be due to a primary dysfunction of colonic smooth muscle (myopathy) or neuronal innervation (neuropathy) or secondary to dyssynergic defecation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212443\">",
"    <span class=\"h3\">",
"     Dyssynergic defecation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyssynergic defecation (DD) is caused by difficulty with or inability expelling stool from the anorectum. Many of these patients may also have prolonged colonic transit time (",
"    <a class=\"graphic graphic_table graphicRef61867 \" href=\"mobipreview.htm?39/11/40123\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212450\">",
"    <span class=\"h3\">",
"     Irritable bowel syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irritable bowel syndrome with predominant constipation (IBS-C) is characterized by abdominal pain with altered bowel habits. These patients may or may not have slow colonic transit or dyssynergia, and many have visceral hypersensitivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/59/22455?source=see_link\">",
"     \"Clinical manifestations and diagnosis of irritable bowel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1058372258\">",
"    <span class=\"h2\">",
"     Secondary causes for constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conditions associated with constipation include endocrine or metabolic disorders, neurologic disorders, myogenic disorders, and medications (",
"    <a class=\"graphic graphic_table graphicRef74971 \" href=\"mobipreview.htm?27/10/27819\">",
"     table 1",
"    </a>",
"    ). Opioid induced constipation is common in those suffering from chronic or cancer-related pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H989691\">",
"    <span class=\"h2\">",
"     Chronic idiopathic constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic idiopathic constipation (CIC) or functional constipation is a common condition affecting the GI tract. Cross-sectional community surveys showed an estimated prevalence between 4 and 20 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/5,16,21,22\">",
"     5,16,21,22",
"    </a>",
"    ]. This functional disorder is defined as the infrequent, persistently difficult passage of stools or seemingly incomplete defecation, which does not meet IBS criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/23\">",
"     23",
"    </a>",
"    ]. These patients usually do not have any physiological abnormality. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link&amp;anchor=H2#H2\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Definition of constipation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212457\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constipation is characterized either by unsatisfactory defecation, infrequent stools, or difficulty with stool passage. In older adults, constipation may be associated with fecal impaction and fecal incontinence. Fecal impaction can cause stercoral ulceration, bleeding, and anemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212464\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in management of constipation in older adults is to exclude secondary causes of constipation. This can often be accomplished with a thorough history and physical examination followed by undertaking the tests outlined below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1058372437\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to elicit a thorough history noting the onset and duration of constipation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link&amp;anchor=H12#H12\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'History'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alarm symptoms (hematochezia, positive fecal occult blood test, obstructive symptoms, acute onset of constipation, severe persistent constipation that is unresponsive to treatment, weight loss &ge;10 pounds, a change in stool caliber, family history of colon cancer or inflammatory bowel disease) should be specifically noted as these will indicate the need for more extensive evaluation.",
"   </p>",
"   <p>",
"    Comorbid issues such as immobility, chronic medical problems, and a medication list should be reviewed. Concurrent psychosocial problems such as social isolation, decreased mobility, poor nutrition, and lack of independence should also be addressed as they can contribute to constipation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1058372501\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comprehensive physical examination should be performed that includes a rectal exam to palpate for hard stool, assess for masses, anal fissures, hemorrhoids, sphincter tone, push effort during attempted defecation, prostatic hypertrophy in males, and posterior vaginal masses in females (",
"    <a class=\"graphic graphic_table graphicRef50031 \" href=\"mobipreview.htm?29/38/30316\">",
"     table 3",
"    </a>",
"    ). This is described in detail separately.",
"    <strong>",
"    </strong>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link&amp;anchor=H13#H13\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212471\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comprehensive metabolic panel, complete blood count, and thyroid function tests can identify metabolic conditions that may be causative as well as secondary anemia that will indicate further evaluation. We recommend routine laboratory testing in older adults with constipation. However, American College of Gastroenterology guidelines state that in patients with chronic constipation without alarm symptoms or signs (hematochezia, weight loss &ge;10 pounds, family history of colon cancer or inflammatory bowel disease, anemia, positive fecal occult blood tests, acute onset of constipation in older adults, and severe persistent constipation that is unresponsive to treatment), there are inadequate data to make a recommendation about the routine use of laboratory tests [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1684048\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data to support the role of imaging in the evaluation of constipation in the older adult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1684949\">",
"    <span class=\"h2\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A colonoscopy allows for direct visualization of the colon to exclude mucosal lesions (eg, solitary rectal ulcer syndrome, inflammation, malignancy) and should be performed in patients if they have alarm symptoms and also as indicated for colorectal cancer screening. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link&amp;anchor=H14#H14\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Endoscopy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/9/38042?source=see_link&amp;anchor=H15#H15\">",
"     \"Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy\", section on 'Colonoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1684055\">",
"    <span class=\"h2\">",
"     Physiologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specialized tests of colorectal function described below may prove useful in defining pathophysiology. These tests are generally reserved for patients with chronic constipation who do not respond to therapy with lifestyle and dietary modifications and a trial of bulk forming and osmotic laxatives. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link&amp;anchor=H18#H18\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Motility studies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Colon transit studies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link&amp;anchor=H17#H17\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Defecography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H152272\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in the treatment of chronic functional constipation is lifestyle and dietary modification. Bulk laxatives are recommended in patients who do not respond to lifestyle and dietary modification. A trial of osmotic laxatives should be considered in patients not responding to bulk laxatives. In patients who fail a trial of osmotic laxatives, colon secretagogues (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/28/38339?source=see_link\">",
"     lubiprostone",
"    </a>",
"    ) should be considered. Stimulant laxatives are efficacious, but chronic use should be avoided as the long-term safety in older adults is not known. Stool softeners and suppositories (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/32/14852?source=see_link\">",
"     glycerin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/4/6213?source=see_link\">",
"     bisacodyl",
"    </a>",
"    ) have limited clinical efficacy. Enemas should only be used to prevent fecal impaction in patients with several days of constipation. Opioid antagonists may have a role in treatment of narcotic-induced constipation and paralytic ileus. In patients with dyssynergic defecation, biofeedback therapy may be helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1684093\">",
"    <span class=\"h2\">",
"     Lifestyle modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;General measures such as increased fluid intake and exercise are suggested to treat constipation, but there is little evidence to support this [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/26\">",
"     26",
"    </a>",
"    ]. In a small study of healthy volunteers, consumption of extra fluid was not associated with an increase in stool output [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is advisable to encourage patients to establish a regular pattern of bowel movement. Most patients who have a normal bowel pattern usually empty stools at approximately the same time every day [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/28\">",
"     28",
"    </a>",
"    ]. This fact suggests that the initiation of defecation is in part a conditioned reflex. Colonic motor activity is more active after waking and after a meal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/29\">",
"     29",
"    </a>",
"    ]. Thus, the optimal time for bowel movement is usually within the first two hours after waking and after breakfast. Other general measures include timed toilet training that consists of educating patients to attempt a bowel movement at least twice a day, usually 30 minutes after meals, and to strain for no more than five minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212541\">",
"    <span class=\"h2\">",
"     Diet and fiber",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fiber increases stool bulk, which causes colonic distention and promotes stool propulsion. A daily fiber intake of 20 to 25",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    is generally recommended. The effects of fiber on bowel movements may take several weeks. Bloating and flatulence is a common problem with increased fiber intake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=see_link&amp;anchor=H30890953#H30890953\">",
"     \"Management of chronic constipation in adults\", section on 'Fiber'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212548\">",
"    <span class=\"h2\">",
"     Laxatives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laxative usage in the older adults should be individualized keeping in mind the patient's history (cardiac and renal comorbidities), drug interactions, cost, and side effects (",
"    <a class=\"graphic graphic_table graphicRef59746 \" href=\"mobipreview.htm?29/62/30701\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1058373674\">",
"    <span class=\"h3\">",
"     Bulk forming laxatives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bulk forming laxatives include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/26/8614?source=see_link\">",
"     psyllium",
"    </a>",
"    seed (eg, Metamucil&reg;),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/28/29123?source=see_link\">",
"     methylcellulose",
"    </a>",
"    (eg, Citrucel&reg;), calcium",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/61/29651?source=see_link\">",
"     polycarbophil",
"    </a>",
"    (eg, FiberCon&reg;), and wheat",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/5/21588?source=see_link\">",
"     dextran",
"    </a>",
"    (eg, Benefiber&reg;) (",
"    <a class=\"graphic graphic_table graphicRef59746 \" href=\"mobipreview.htm?29/62/30701\">",
"     table 4",
"    </a>",
"    ). They are natural or synthetic polysaccharides or cellulose derivatives that primarily exert their laxative effect by absorbing water and increasing fecal mass. These laxatives are effective in increasing the frequency and softening the consistency of stool with a minimum of adverse effects. They may be used alone or in combination with an increase in dietary fiber.",
"   </p>",
"   <p>",
"    Despite substantial anecdotal clinical experience indicating benefit for bulk forming laxatives, objective evidence regarding the effectiveness is inconsistent. A systematic review found evidence that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/26/8614?source=see_link\">",
"     psyllium",
"    </a>",
"    increases stool frequency in patients with chronic constipation but found insufficient evidence for other forms of fiber including calcium",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/61/29651?source=see_link\">",
"     polycarbophil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/28/29123?source=see_link\">",
"     methylcellulose",
"    </a>",
"    , and bran [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/25\">",
"     25",
"    </a>",
"    ]. Another review found evidence supporting the efficacy and safety of calcium polycarbophil, but poor evidence supporting the use of psyllium and methylcellulose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/33\">",
"     33",
"    </a>",
"    ]. One study showed that dried plums (prunes) were more effective than psyllium as first line therapy in the treatment of mild to moderate constipation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1058373646\">",
"    <span class=\"h3\">",
"     Osmotic laxatives",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trial of osmotic laxatives should be considered in patients not responding to bulking agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/17/4374?source=see_link\">",
"     polyethylene glycol",
"    </a>",
"    (PEG) (17",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    has been demonstrated to be efficacious and well tolerated in older patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. However, high-dose PEG (34",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    is associated with abdominal bloating, cramping, and flatulence, and older adults may be more susceptible to these side effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/34/33316?source=see_link\">",
"     Lactulose",
"    </a>",
"    increases stool frequency, decreases the severity of constipation symptoms, and reduces the need for other laxatives in older adult patients compared with placebo. However, in one study, lactulose was less effective than low-dose PEG and also had a higher incidence of flatus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/0/29699?source=see_link\">",
"     Sorbitol",
"    </a>",
"    was shown to be as efficacious as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/34/33316?source=see_link\">",
"     lactulose",
"    </a>",
"    in a four-week study of constipated older adult patients and was less expensive and better tolerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Saline laxatives such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/6/31847?source=see_link\">",
"     magnesium hydroxide",
"    </a>",
"    have not been examined in older adults, and should be used with caution because of the risk of hypermagnesemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1058373655\">",
"    <span class=\"h3\">",
"     Stimulant laxatives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stimulant laxatives affect electrolyte transport across the intestinal mucosa and enhance colonic transport and motility. In one study,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40276?source=see_link\">",
"     senna",
"    </a>",
"    , the stimulant laxative, in combination with fiber was associated with improved stool consistency, frequency, and ease of stool passage when compared with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/34/33316?source=see_link\">",
"     lactulose",
"    </a>",
"    in older nursing home residents, and appeared equally well tolerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/4/6213?source=see_link\">",
"     Bisacodyl",
"    </a>",
"    was evaluated in a randomized, double-blind, placebo-controlled, parallel-group study in which patients were randomized to bisacodyl (10 mg) or placebo for four weeks. The mean number of complete spontaneous bowel movements (CSBMs) per week, the number of spontaneous bowel movements (SBMs), constipation-associated symptoms, and quality of life were significantly improved in the bisacodyl group compared to placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/40\">",
"     40",
"    </a>",
"    ]. Treatment with bisacodyl was also well tolerated. However, the long-term safety of stimulant laxatives has not been established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212555\">",
"    <span class=\"h2\">",
"     Stool softeners, suppositories, and enemas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stool softeners, suppositories (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/32/14852?source=see_link\">",
"     glycerin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/4/6213?source=see_link\">",
"     bisacodyl",
"    </a>",
"    ), and enemas, although widely used, have limited clinical efficacy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/24,33\">",
"     24,33",
"    </a>",
"    ]. Glycerin or bisacodyl suppositories can be used in institutionalized older adults with dyssynergic defecation to help with rectal evacuation.",
"   </p>",
"   <p>",
"    Enemas (tap water,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/22/5480?source=see_link\">",
"     sodium phosphate",
"    </a>",
"    , soapsuds) should be used only as needed for constipation in the older adult, ie, after several days of constipation in order to prevent fecal impaction. Adverse effects can include electrolyte abnormalities with phosphate enemas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/41\">",
"     41",
"    </a>",
"    ] and rectal mucosal damage with soapsuds enemas. In a retrospective series, the use of sodium phosphate enemas in older adults (mean age 80 years, only one of whom was younger than age 70 years) was associated with complications including hypotension and volume depletion, hyperphosphatemia, hypo- or hyperkalemia, metabolic acidosis, severe hypocalcemia, renal failure, and EKG changes (prolonged QT interval) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/42\">",
"     42",
"    </a>",
"    ]. In patients over the age of 70 years, we suggest that sodium phosphate enemas not be used for the treatment of constipation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212562\">",
"    <span class=\"h2\">",
"     Other therapies for chronic constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several agents have been studied or are undergoing further studies for the treatment of chronic constipation. These include colonic secretagogues, opioid antagonists, and 5HT",
"    <sub>",
"     4",
"    </sub>",
"    receptor agonists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212576\">",
"    <span class=\"h3\">",
"     Colonic secretagogues",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/28/38339?source=see_link\">",
"     Lubiprostone",
"    </a>",
"    is an oral bicyclic fatty acid that activates the type 2 chloride channels on the intestinal epithelial cells, thus secreting chloride and water into the gut lumen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/20\">",
"     20",
"    </a>",
"    ]. In two phase III studies of four weeks duration, lubiprostone 24&nbsp;mcg daily significantly enhanced bowel movement frequency and relieved other constipation-related symptoms compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. In a subgroup analysis, lubiprostone also demonstrated efficacy in older patients. It is best reserved for patients with severe constipation in whom other approaches have been unsuccessful.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/17/20755?source=see_link\">",
"     Linaclotide",
"    </a>",
"    is a guanylate cyclase C receptor agonist that stimulates intestinal fluid secretion and transit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/45\">",
"     45",
"    </a>",
"    ]. In two large phase 3 trials of patients with chronic constipation, the linaclotide treated groups (both 145 microgram and 290 microgram) had significantly higher rates of three or more complete spontaneous bowel movements (CSBM) per week and an increase in one or more CSBMs from baseline during at least 9 out of 12 weeks as compared with placebo (145 micrograms: 21 and 16 percent, 290 micrograms: 19 and 21 percent, versus placebo: 3 and 6 percent). The most common and dose-related adverse event was diarrhea that led to discontinuation of treatment in 4 percent of patients in both linaclotide-treated groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/46\">",
"     46",
"    </a>",
"    ]. Although linaclotide has been approved by the US Food and Drug Administration for use in the treatment of chronic idiopathic constipation, the long-term risks and benefits of linaclotide, especially in older adults, remain to be determined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=see_link&amp;anchor=H1747782838#H1747782838\">",
"     \"Management of chronic constipation in adults\", section on 'Linaclotide'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1401496670\">",
"    <span class=\"h3\">",
"     Opioid antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two peripherally acting mu opioid receptor antagonists,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/7/5236?source=see_link\">",
"     alvimopan",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/29/2516?source=see_link\">",
"     methylnaltrexone",
"    </a>",
"    , may have a role in treatment of narcotic-induced constipation and paralytic ileus, but data are lacking among older adults. As these opioid receptor antagonists act peripherally and do not cross the blood brain barrier, they do not impair the analgesic effects of opioids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1401496646\">",
"    <span class=\"h3\">",
"     5HT(4) receptor agonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serotonin (5HT) is a key regulator of gastrointestinal motility.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/10/18596?source=see_link\">",
"     Prucalopride",
"    </a>",
"    is a selective high affinity 5HT",
"    <sub>",
"     4",
"    </sub>",
"    receptor agonist. In a dose of 1 and 4 mg once daily, prucalopride has been shown to be superior to placebo in 4- and 12-week trials, and safe and well tolerated in patients age 65 years or older [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. In clinical trials, prucalopride 2 mg provided comparable efficacy to 4 mg and it is therefore the widely used dosage in clinical practice. The dose of prucalopride can be titrated up based on clinical response. Prucalopride is available in Europe and Canada, but not in the United States.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212590\">",
"    <span class=\"h2\">",
"     Biofeedback",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biofeedback therapy is a painless, noninvasive means of cognitively retraining the pelvic floor and the abdominal wall musculature. Patients are guided to improve control of these muscles by electromyographic surface electrodes on an anal plug and an abdominal wall surface electrode. For patients with pelvic floor",
"    <strong>",
"    </strong>",
"    dysfunction, particularly dyssynergic defecation, biofeedback therapy should be considered.",
"   </p>",
"   <p>",
"    Four randomized controlled trials have evaluated the efficacy of biofeedback therapy in the treatment of dyssynergic defecation and concluded that biofeedback is consistently superior to laxatives, standard therapy, sham therapy, placebo, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35048/abstract/50-53\">",
"     50-53",
"    </a>",
"    ]. Trials are needed to establish the efficacy of biofeedback in older adults. Until then an individualized assessment of the physical and mental capacity of the older adult is important in evaluating the potential efficacy of biofeedback. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=see_link&amp;anchor=H30890995#H30890995\">",
"     \"Management of chronic constipation in adults\", section on 'Biofeedback'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H523121797\">",
"    <span class=\"h1\">",
"     FECAL IMPACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constipation plays an important role in the development of fecal impaction and incontinence in older and institutionalized adults. Fecal impaction results largely from the person's inability to sense and respond to the presence of stool in the rectum. Decreased mobility and lowered sensory perception are common causes of fecal impaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H523121865\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of fecal impaction is confirmed by performing a digital rectal examination. The impacted stool is not necessarily hard, but the key to the diagnosis of fecal impaction is in finding a copious amount of stool in the rectum. It is important to note that fecal impactions can occur in the proximal rectum or sigmoid colon, and a digital rectal examination will be nondiagnostic. If the clinical suspicion for a fecal impaction is high, an abdominal radiograph should be obtained to detect fecal loading in the absence of a rectal impaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H523121835\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of a suspected perforation or massive bleeding, the management of fecal impactions involves disimpaction and colon evacuation, followed by the implementation of a maintenance bowel regimen to prevent recurrent impactions. We suggest",
"    <strong>",
"    </strong>",
"    digital disimpaction to fragment a large fecal bolus to facilitate its passage through the anal canal. Subsequently a warm-water enema with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13316?source=see_link\">",
"     mineral oil",
"    </a>",
"    may be administered to soften the impaction and assist emptying of stool from the rectum and distal colon. Once the distal colon has been partially emptied with disimpaction and enemas,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/17/4374?source=see_link\">",
"     polyethylene glycol",
"    </a>",
"    (PEG) may be administered orally or by a nasogastric tube.",
"   </p>",
"   <p>",
"    If the above measures fail, local anesthesia to relax the anal canal and pelvic floor muscles, together with abdominal massage, can help to pass the stool bolus. In rare cases, it may be necessary to use a colonoscope with a snare to fragment fecal material in the distal colon. In such cases, a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13316?source=see_link\">",
"     mineral oil",
"    </a>",
"    enema prior to the colonoscopy may help to soften the stool bolus. If such measures fail or if there is significant abdominal tenderness suggestive of an impending perforation or ischemia, surgery may be necessary.",
"   </p>",
"   <p>",
"    Following management of an acute impaction, it is important to identify and eliminate potential causes of constipation. This includes discontinuing medications that cause or exacerbate constipation. For the institutionalized adult, improving availability of toileting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    providing assistance is necessary to prevent constipation. Regular use of medications that treat constipation in the older adult is discussed above. (See",
"    <a class=\"local\" href=\"#H29212548\">",
"     'Laxatives'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29212597\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Constipation is defined as any two of the following features: straining, lumpy hard stools, sensation of incomplete evacuation, use of digital maneuvers, sensation of anorectal obstruction or blockage with 25 percent of bowel movements, and decrease in stool frequency (less than three bowel movements per week). (See",
"      <a class=\"local\" href=\"#H29212415\">",
"       'Definition of constipation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Constipation in the older adult may be due to functional chronic constipation or secondary to other etiologic factors.",
"      <br/>",
"      <br/>",
"      Primary colorectal dysfunction consists of three overlapping subtypes: slow transit constipation, dyssynergic defecation, and irritable bowel syndrome with constipation. Secondary causes of constipation should be excluded with a thorough history and physical examination followed by diagnostic testing. (See",
"      <a class=\"local\" href=\"#H29212429\">",
"       'Pathophysiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H29212464\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The first step in the treatment of chronic functional constipation is with lifestyle and dietary modification. A daily fiber intake of 20 to 25",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      is generally recommended. (See",
"      <a class=\"local\" href=\"#H1684093\">",
"       'Lifestyle modification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H29212541\">",
"       'Diet and fiber'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laxative usage in the older adults should be individualized based on the patient's history, comorbidities, drug interactions, and side effects.",
"      <br/>",
"      <br/>",
"      We suggest bulk laxatives (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/26/8614?source=see_link\">",
"       psyllium",
"      </a>",
"      ) as the first line of therapy in older patients with chronic constipation who do not respond to dietary and lifestyle modification (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Osmotic laxatives can be used in patients not responding satisfactorily to bulking agents. We suggest a trial of low-dose",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/17/4374?source=see_link\">",
"       polyethylene glycol",
"      </a>",
"      (PEG) as it has been demonstrated to be efficacious and well tolerated in older adults.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/34/33316?source=see_link\">",
"       Lactulose",
"      </a>",
"      is less effective than low-dose PEG and also had a higher incidence of flatus.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/0/29699?source=see_link\">",
"       Sorbitol",
"      </a>",
"      has shown to be as efficacious as lactulose, less expensive, and better tolerated. Saline laxatives such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/6/31847?source=see_link\">",
"       magnesium hydroxide",
"      </a>",
"      have not been examined in older adults, and should be used with caution because of the risk of hypermagnesemia. (See",
"      <a class=\"local\" href=\"#H29212548\">",
"       'Laxatives'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stool softeners, suppositories (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/32/14852?source=see_link\">",
"       glycerin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/4/6213?source=see_link\">",
"       bisacodyl",
"      </a>",
"      ), and enemas have limited clinical efficacy and should only be used in specific clinical scenarios. (See",
"      <a class=\"local\" href=\"#H29212555\">",
"       'Stool softeners, suppositories, and enemas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients over the age of 70 years being treated with enemas for constipation, we suggest that patients receive warm water enemas rather than",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/22/5480?source=see_link\">",
"       sodium phosphate",
"      </a>",
"      enemas (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The use of sodium phosphate enemas in older adults has been associated with complications including hypotension and volume depletion, hyperphosphatemia, hypo- or hyperkalemia, metabolic acidosis, severe hypocalcemia, renal failure, and EKG changes (prolonged QT interval).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/28/38339?source=see_link\">",
"       Lubiprostone",
"      </a>",
"      , a type 2 chloride channels activator, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/17/20755?source=see_link\">",
"       linaclotide",
"      </a>",
"      , a guanylate cyclase agonist, significantly enhance bowel movement frequency and relieve other constipation-related symptoms. However, the long-term risks and benefits of linaclotide, especially in older adults, remain to be determined. (See",
"      <a class=\"local\" href=\"#H29212562\">",
"       'Other therapies for chronic constipation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Peripherally acting mu opioid receptor antagonists,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/7/5236?source=see_link\">",
"       alvimopan",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/29/2516?source=see_link\">",
"       methylnaltrexone",
"      </a>",
"      , may have a role in treatment of narcotic-induced constipation and paralytic ileus, but data are lacking among older adults. (See",
"      <a class=\"local\" href=\"#H29212562\">",
"       'Other therapies for chronic constipation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biofeedback therapy is a painless, noninvasive means of cognitively retraining the pelvic floor and the abdominal wall musculature. Randomized controlled trials have established the efficacy of biofeedback therapy in the treatment of dyssynergic defecation. However, trials are needed to establish the efficacy of biofeedback in older adults. (See",
"      <a class=\"local\" href=\"#H29212590\">",
"       'Biofeedback'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H104197852\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Narasimha Palagummi, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/1\">",
"      Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol 1997; 32:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/2\">",
"      Drossman DA, Sandler RS, McKee DC, Lovitz AJ. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982; 83:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/3\">",
"      Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ 3rd. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992; 102:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/4\">",
"      Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol 1996; 91:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/5\">",
"      Wald A, Scarpignato C, Mueller-Lissner S, et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther 2008; 28:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/6\">",
"      Sandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Public Health 1990; 80:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/7\">",
"      Everhart JE, Go VL, Johannes RS, et al. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989; 34:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/8\">",
"      Whitehead WE, Drinkwater D, Cheskin LJ, et al. Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc 1989; 37:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/9\">",
"      Donald IP, Smith RG, Cruikshank JG, et al. A study of constipation in the elderly living at home. Gerontology 1985; 31:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/10\">",
"      Harari D, Gurwitz JH, Avorn J, et al. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med 1996; 156:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/11\">",
"      Choung RS, Locke GR 3rd, Schleck CD, et al. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther 2007; 26:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/12\">",
"      Ruby CM, Fillenbaum GG, Kuchibhatla MN, Hanlon JT. Laxative use in the community-dwelling elderly. Am J Geriatr Pharmacother 2003; 1:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/13\">",
"      Harari D, Gurwitz JH, Avorn J, et al. Constipation: assessment and management in an institutionalized elderly population. J Am Geriatr Soc 1994; 42:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/14\">",
"      Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord 2004; 4 Suppl 2:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/15\">",
"      Primrose WR, Capewell AE, Simpson GK, Smith RG. Prescribing patterns observed in registered nursing homes and long-stay geriatric wards. Age Ageing 1987; 16:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/16\">",
"      Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999; 94:3530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/17\">",
"      Towers AL, Burgio KL, Locher JL, et al. Constipation in the elderly: influence of dietary, psychological, and physiological factors. J Am Geriatr Soc 1994; 42:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/18\">",
"      Whitehead W, Wald A, Diamant N, et al. Functional disorders of the anus and rectum. Gut 1999; 45:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/19\">",
"      Rao SS, Welcher KD, Leistikow JS. Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol 1998; 93:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/20\">",
"      Rao SS, Go JT. Update on the management of constipation in the elderly: new treatment options. Clin Interv Aging 2010; 5:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/21\">",
"      Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/22\">",
"      Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology 1993; 105:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/23\">",
"      Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/24\">",
"      Bouras EP, Tangalos EG. Chronic constipation in the elderly. Gastroenterol Clin North Am 2009; 38:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/25\">",
"      American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005; 100 Suppl 1:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/26\">",
"      Lindeman RD, Romero LJ, Liang HC, et al. Do elderly persons need to be encouraged to drink more fluids? J Gerontol A Biol Sci Med Sci 2000; 55:M361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/27\">",
"      Chung BD, Parekh U, Sellin JH. Effect of increased fluid intake on stool output in normal healthy volunteers. J Clin Gastroenterol 1999; 28:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/28\">",
"      Heaton EA. The call to stool and its relationship to constipation: A community study. Eur J Gastroenterol Hepatol 1994; 6:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/29\">",
"      Rao SS, Kavelock R, Beaty J, et al. Effects of fat and carbohydrate meals on colonic motor response. Gut 2000; 46:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/30\">",
"      Rao SS. Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastrointest Endosc Clin N Am 2009; 19:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/31\">",
"      Gallagher P, O'Mahony D. Constipation in old age. Best Pract Res Clin Gastroenterol 2009; 23:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/32\">",
"      Locke GR 3rd, Pemberton JH, Phillips SF. American Gastroenterological Association Medical Position Statement: guidelines on constipation. Gastroenterology 2000; 119:1761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/33\">",
"      Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 2005; 100:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/34\">",
"      Attaluri A, Donahoe R, Valestin J, et al. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther 2011; 33:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/35\">",
"      Attar A, L&eacute;mann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999; 44:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/36\">",
"      Brandt LJ, Prather CM, Quigley EM, et al. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005; 100 Suppl 1:S5.",
"     </a>",
"    </li>",
"    <li>",
"     Garlehner G, Jonas DE, Morgan LC, et al. Drug class review on constipation drugs, Oregon Health &amp; Science University, Portland, OR 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/38\">",
"      Lederle FA, Busch DL, Mattox KM, et al. Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose. Am J Med 1990; 89:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/39\">",
"      Passmore AP, Davies KW, Flanagan PG, et al. A comparison of Agiolax and lactulose in elderly patients with chronic constipation. Pharmacology 1993; 47 Suppl 1:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/40\">",
"      Kamm MA, Mueller-Lissner S, Wald A, et al. Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol 2011; 9:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/41\">",
"      Mendoza J, Legido J, Rubio S, Gisbert JP. Systematic review: the adverse effects of sodium phosphate enema. Aliment Pharmacol Ther 2007; 26:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/42\">",
"      Ori Y, Rozen-Zvi B, Chagnac A, et al. Fatalities and severe metabolic disorders associated with the use of sodium phosphate enemas: a single center's experience. Arch Intern Med 2012; 172:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/43\">",
"      Johanson JF, Morton D, Geenen J, Ueno R. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol 2008; 103:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/44\">",
"      Barish CF, Drossman D, Johanson JF, Ueno R. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci 2010; 55:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/45\">",
"      Lembo AJ, Kurtz CB, Macdougall JE, et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology 2010; 138:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/46\">",
"      Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med 2011; 365:527.",
"     </a>",
"    </li>",
"    <li>",
"     FDA approves Linzess to treat certain cases of irritable bowel syndrome and constipation. Available at: file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm317505.htm (Accessed on September 04, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/48\">",
"      Quigley EM, Vandeplassche L, Kerstens R, Ausma J. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2009; 29:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/49\">",
"      M&uuml;ller-Lissner S, Rykx A, Kerstens R, Vandeplassche L. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation. Neurogastroenterol Motil 2010; 22:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/50\">",
"      Rao SS, Seaton K, Miller M, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol 2007; 5:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/51\">",
"      Chiarioni G, Whitehead WE, Pezza V, et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology 2006; 130:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/52\">",
"      Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology 2005; 129:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35048/abstract/53\">",
"      Heymen S, Scarlett Y, Jones K, et al. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum 2007; 50:428.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16133 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-2972EEEA2C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35048=[""].join("\n");
var outline_f34_14_35048=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29212597\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29212408\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29212415\">",
"      DEFINITION OF CONSTIPATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29212422\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29212429\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1058372251\">",
"      Primary colorectal dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29212436\">",
"      - Slow transit constipation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29212443\">",
"      - Dyssynergic defecation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29212450\">",
"      - Irritable bowel syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1058372258\">",
"      Secondary causes for constipation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H989691\">",
"      Chronic idiopathic constipation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29212457\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29212464\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1058372437\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1058372501\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29212471\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1684048\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1684949\">",
"      Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1684055\">",
"      Physiologic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H152272\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1684093\">",
"      Lifestyle modification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29212541\">",
"      Diet and fiber",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29212548\">",
"      Laxatives",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1058373674\">",
"      - Bulk forming laxatives",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1058373646\">",
"      - Osmotic laxatives",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1058373655\">",
"      - Stimulant laxatives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29212555\">",
"      Stool softeners, suppositories, and enemas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29212562\">",
"      Other therapies for chronic constipation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29212576\">",
"      - Colonic secretagogues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1401496670\">",
"      - Opioid antagonists",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1401496646\">",
"      - 5HT(4) receptor agonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29212590\">",
"      Biofeedback",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H523121797\">",
"      FECAL IMPACTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H523121865\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H523121835\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29212597\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H104197852\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/16133\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/16133|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/10/27819\" title=\"table 1\">",
"      Causes of secondary constipation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/11/40123\" title=\"table 2\">",
"      Criteria for dyssynergic defecation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/38/30316\" title=\"table 3\">",
"      Technique and findings with a digital rectal examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/62/30701\" title=\"table 4\">",
"      Laxatives",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/59/22455?source=related_link\">",
"      Clinical manifestations and diagnosis of irritable bowel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15354?source=related_link\">",
"      Constipation in children: Etiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=related_link\">",
"      Etiology and evaluation of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=related_link\">",
"      Management of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/9/38042?source=related_link\">",
"      Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/28/36298?source=related_link\">",
"      Treatment of chronic functional constipation and fecal incontinence in infants and children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_14_35049="POEMS syndrome";
var content_f34_14_35049=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   POEMS syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35049/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35049/contributors\">",
"     S Vincent Rajkumar, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35049/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35049/contributors\">",
"     Robert A Kyle, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/14/35049/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/14/35049/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/14/35049/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;POEMS syndrome (",
"    <strong>",
"     P",
"    </strong>",
"    olyneuropathy,",
"    <strong>",
"     O",
"    </strong>",
"    rganomegaly,",
"    <strong>",
"     E",
"    </strong>",
"    ndocrinopathy,",
"    <strong>",
"     M",
"    </strong>",
"    onoclonal protein,",
"    <strong>",
"     S",
"    </strong>",
"    kin changes) is characterized by the presence of a monoclonal plasma cell disorder, peripheral neuropathy, and one or more of the following features: osteosclerotic myeloma, Castleman's disease, increased levels of serum vascular endothelial growth factor (VEGF), organomegaly, endocrinopathy, edema, typical skin changes, and papilledema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features, diagnosis, and treatment of POEMS syndrome will be discussed here. A discussion of Castleman's disease is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/51/6970?source=see_link\">",
"     \"Castleman's disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORICAL BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1938, a patient was described with sensorimotor peripheral neuropathy, hyperpigmentation, elevated cerebrospinal fluid protein, and a solitary plasmacytoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/2\">",
"     2",
"    </a>",
"    ]. Eighteen years later, two patients were reported with peripheral neuropathy, hyperpigmentation, elevation of cerebrospinal fluid protein, and plasmacytomas with new bone formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/3\">",
"     3",
"    </a>",
"    ]. In 1980 the acronym \"POEMS\" was suggested for this disorder, representing the following constellation of findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Polyneuropathy",
"     </li>",
"     <li>",
"      Organomegaly",
"     </li>",
"     <li>",
"      Endocrinopathy",
"     </li>",
"     <li>",
"      Monoclonal protein",
"     </li>",
"     <li>",
"      Skin changes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional features described in this syndrome include sclerotic bone lesions, Castleman's disease, papilledema, pleural effusion, edema, ascites, erythrocytosis, and thrombocytosis. This disorder has also been called osteosclerotic myeloma, Crow-Fukase syndrome, PEP syndrome (plasma cell dyscrasia, endocrinopathy, polyneuropathy), or Takatsuki syndrome. The complex interrelationships among POEMS syndrome, osteosclerotic myeloma, and Castleman's disease are still being investigated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6653014\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of POEMS syndrome is unknown, although chronic overproduction of pro-inflammatory and other cytokines (eg, vascular endothelial growth factor) appears to be a major feature of this disorder, with microangiopathy, edema, effusions, and increased vascular permeability, neovascularization, polyneuropathy, pulmonary hypertension, leukocytosis, and thrombocytosis as possible examples of their effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/5-7\">",
"     5-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients frequently have higher levels of interleukin-1&szlig; (IL-1&szlig;), tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6) than patients with multiple myeloma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/5\">",
"     5",
"    </a>",
"    ]. It has been postulated that manifestations of POEMS syndrome might be regarded as the result of a marked activation of these cytokines associated with a weak or decreased TGF-&szlig;1 antagonistic reaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/5\">",
"     5",
"    </a>",
"    ]. Serum IL-6 levels in six patients with active POEMS syndrome were higher than those with stable POEMS; elevated levels of serum IL-6 increased before each exacerbation of clinical symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/8\">",
"     8",
"    </a>",
"    ]. Elevated levels of IL-6 have also been reported in pericardial fluid in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Others have demonstrated that platelets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/10\">",
"     10",
"    </a>",
"    ] or plasma cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/11,12\">",
"     11,12",
"    </a>",
"    ] were a major source of vascular endothelial growth factor (VEGF), a potent inducer of increased vascular permeability. In addition, elevated levels of VEGF were noted to decrease significantly in patients with POEMS syndrome following successful therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/7,13,14\">",
"     7,13,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/60/1994?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of angiogenesis inhibitors\", section on 'Vascular endothelial growth factor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Elevation of matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP-1) have also been reported in POEMS syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of POEMS syndrome are protean. By definition, all patients have peripheral neuropathy and a monoclonal plasma cell disorder, almost always of the lambda light chain type. In addition, almost all patients have either osteosclerotic myeloma (solitary or multiple) or Castleman's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. One should therefore be cautious about diagnosing POEMS syndrome in the absence of either osteosclerotic lesions or Castleman's disease. The prevalence of other manifestations (eg, organomegaly, endocrinopathy, skin changes, edema, and papilledema) varies greatly (",
"    <a class=\"graphic graphic_table graphicRef66534 \" href=\"mobipreview.htm?26/5/26716\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In a Mayo Clinic series of 99 patients with this syndrome, the median age was 51 years (range: 30 to 83) and 63 percent were males.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Peripheral neuropathy and CNS involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral neuropathy is required for the diagnosis of POEMS syndrome, and usually dominates the clinical picture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. Symptoms begin in the feet and consist of tingling, paresthesias, and feelings of coldness. Motor involvement follows the sensory symptoms. Both are distal, symmetric, and progressive, with a gradual proximal spread. Severe weakness occurs in more than half of patients and results in an inability to climb stairs, arise from a chair, or grip objects firmly with the hands, consistent with a predominantly motor chronic inflammatory demyelinating polyneuropathy. The course is progressive and patients may be confined to a wheelchair. Autonomic symptoms are not a feature. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Mayo Clinic criteria'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Physical examination reveals a symmetric sensorimotor neuropathy involving the extremities. Muscle weakness is more marked than sensory loss. Touch, pressure, vibratory, and joint position senses are often involved. Less frequently, loss of temperature discrimination and nociception occurs. Cranial nerves are not affected.",
"   </p>",
"   <p>",
"    Cerebrospinal fluid protein levels are increased in virtually all patients, with more than half of patients having a cerebrospinal fluid protein level &gt;100",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/16\">",
"     16",
"    </a>",
"    ]. The total cell count is typically normal.",
"   </p>",
"   <p>",
"    Electromyographic studies show slowing of nerve conduction, prolonged distal latencies, and severe attenuation of compound muscle action potentials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. Conduction block is rarely found [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/17\">",
"     17",
"    </a>",
"    ], but slowing of motor conduction is proportionately greater than the reduction in the compound muscle action potential amplitude. Distal fibrillation potentials are found on needle electromyography.",
"   </p>",
"   <p>",
"    Biopsy of the sural nerve usually shows both axonal degeneration and demyelination; severe endoneurial edema may also be seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. A loss of myelinated fibers and an increased frequency of axonal degeneration in teased fibers have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/18\">",
"     18",
"    </a>",
"    ], along with high expression of VEGF in vasa nervorum and some non-myelin- forming Schwann cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/7\">",
"     7",
"    </a>",
"    ]. Endoneurial deposits of immunoglobulins of the same type as in the serum have been reported in three of four patients with POEMS syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Papilledema was seen in 29 percent of patients with POEMS in the Mayo Clinic series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ] and in 40 to 55 percent of patients in the two other major series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Organomegaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fifty percent of patients in the Mayo Clinic series had organomegaly (hepatomegaly, splenomegaly,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lymphadenopathy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. Each was present in about one-fourth of the patients. These figures are lower than those seen in two other major series, in which hepatomegaly, splenomegaly, and lymphadenopathy were present in 68 to 78, 35 to 52, and 52 to 61 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. When present, organomegaly is mild, and massive enlargement of any of these organs is unusual. In the few liver biopsies that were performed, only non-specific reactive changes were found, without an infiltrative process.",
"   </p>",
"   <p>",
"    Biopsy of enlarged lymph nodes, if present, reveals either Castleman's disease or reactive changes (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Castleman's disease'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Endocrine abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous endocrine abnormalities have been described. Findings based on the Mayo Clinic series are listed below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1,22\">",
"     1,22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two-thirds of patients had at least one endocrine abnormality at presentation. Endocrine abnormalities can also develop later, during the course of the disease, for a total incidence of 84 percent in our series [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hypogonadism is the most common endocrine abnormality. Elevated levels of follicle stimulating hormone (FSH) in the absence of primary hypogonadism levels have been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/23\">",
"       23",
"      </a>",
"      ]. Over 70 percent of males have erectile dysfunction and all but 4 of the 28 who had serum testosterone levels measured had a reduction. Seventeen men had gynecomastia without elevation of prolactin levels. Two women had irregular menses, one of whom also had galactorrhea; serum estradiol levels were normal in all four women in whom it was measured.",
"     </li>",
"     <li>",
"      Fourteen patients had hypothyroidism requiring therapy. An additional 12 percent had a mild increase in thyroid stimulating hormone level but normal thyroxine levels.",
"     </li>",
"     <li>",
"      Sixteen percent had abnormalities of the adrenal-pituitary axis at presentation; five additional patients developed adrenal insufficiency later in the course of their disease. Three percent of patients had diabetes mellitus. Serum levels of parathyroid hormone were increased in three of four patients in whom it was measured.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Monoclonal plasma cell disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients by definition must have evidence of a monoclonal plasma cell proliferative disorder, either on serum",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    urine immunofixation studies, or on immunostaining or flow cytometric studies done on the bone marrow. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Mayo Clinic criteria'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Findings based on the Mayo Clinic series are listed below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eighty-five percent had a monoclonal protein in the serum. The magnitude of serum monoclonal protein was small, with a median serum M-spike of 1.1",
"      <span class=\"nowrap\">",
"       g/dL;",
"      </span>",
"      only seven patients had an M-spike of more than 2",
"      <span class=\"nowrap\">",
"       g/dL.",
"      </span>",
"      This is similar to the 75 percent reported in another series of 102 patients with this syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Serum protein electrophoresis is normal in one-fourth of patients and some patients can have a pattern suggesting the presence of a polyclonal gammopathy. In these patients the monoclonal protein can be overlooked if immunofixation is not performed. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/58/10154?source=see_link\">",
"       \"Recognition of monoclonal proteins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Overall, 88 percent of patients had a monoclonal protein in the serum",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      urine. Of these, 40 patients had a monoclonal protein in the urine; the amount was small, with a median value of 100",
"      <span class=\"nowrap\">",
"       mg/24",
"      </span>",
"      hours.",
"     </li>",
"     <li>",
"      The type of light chain seen in POEMS syndrome is almost always lambda [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/24\">",
"       24",
"      </a>",
"      ]. The associated heavy chain was IgA, IgG, or IgM in 44, 40, and one patient each, respectively.",
"     </li>",
"     <li>",
"      A clonal lambda plasma cell proliferative process was demonstrated by immunohistochemical staining of biopsy specimens in all 12 patients who did not have a monoclonal protein in their serum or urine.",
"     </li>",
"     <li>",
"      A random bone marrow examination is most often nondiagnostic, showing a hypercellular, \"reactive-appearing\", or normal-appearing marrow. Less than 15 percent have bone marrow plasmacytosis &gt;10 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1,20,21\">",
"       1,20,21",
"      </a>",
"      ]. Less than 5 percent have &gt;20 percent plasma cells, but this is not accompanied by lytic bone lesions or anemia suggestive of the diagnosis of multiple myeloma. An increase in plasma cells is typically only seen in sclerotic bone lesions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H614257969\">",
"    <span class=\"h2\">",
"     Vascular endothelial growth factor (VEGF) levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevation of serum or plasma VEGF levels is an important feature of the POEMS syndrome, and can be followed to assess response to therapy. However, the normal reference ranges for these tests, and the optimal cut-off for the diagnosis of POEMS are not well defined. In general, serum VEGF levels tend to be more than five- to 10-fold higher in POEMS syndrome compared with normal controls and those seen in other neuropathic disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/13,25\">",
"     13,25",
"    </a>",
"    ]. However, serum levels of VEGF are affected by the unpredictable release of platelet-derived VEGF because of ex vivo platelet activation during the clotting process as well as the presence of thrombocytosis in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Plasma VEGF levels appear to be at least as good as, if not better than, serum levels. In a study of 105 patients (29 with POEMS, 9 with Castleman disease, 15 with monoclonal plasma cell disorders, 52 with other disorders), a plasma VEGF level &gt;200",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    had a sensitivity and specificity of 68 and 95 percent, respectively, in support of a diagnosis of POEMS syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this study, all patients who had treatment showed both clinical improvement as well as a reduction in plasma levels of VEGF. However, there was no significant difference in plasma VEGF levels on day 180 or last follow-up between those who did or did not achieve complete clinical remission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Skin changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overall, skin changes (hyperpigmentation, hypertrichosis, acrocyanosis, plethora,",
"    <span class=\"nowrap\">",
"     hemangioma/telangiectasia)",
"    </span>",
"    are noted in two-thirds of patients. The major dermatologic findings consist of hyperpigmentation and hemangiomas, with the latter having histopathological features similar to those found in renal glomeruli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hyperpigmentation is present in almost one-half of patients; this finding can be easily overlooked. Hypertrichosis, manifested by coarse black hair, appears on the extremities in one-fourth of patients. It is either generalized or limited to certain body areas, such as the extremities or face. Occasional patients have skin thickening. Acrocyanosis and plethora are seen in approximately 20 percent of patients. Telangiectasia and hemangiomas (present in 10 percent of cases) are less frequent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Bone lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteosclerotic lesions appeared in conventional radiographs in 97 percent of patients in the Mayo Clinic study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. Forty-seven percent had only sclerotic lesions, 51 percent had mixed sclerotic and lytic lesions, while lytic lesions without evidence of sclerosis were seen in only 2 percent of our patients with bone lesions. These lesions may be small in size and misinterpreted as benign bony sclerosis. In addition, a small sclerotic rim surrounding a large lytic lesion may be easily overlooked.",
"   </p>",
"   <p>",
"    A solitary osteosclerotic bone lesion is found in 45 percent of patients, while the remainder have multiple lesions. The pelvis, spine, ribs, and proximal extremities were most often involved. Bone pain and pathologic fractures are rare; hypercalcemia does not occur at presentation. Although osteosclerotic myeloma is a characteristic feature of POEMS syndrome, there are occasional patients with multiple myeloma who have osteosclerotic bone lesions in the absence of POEMS syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Castleman's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Castleman's disease (giant cell lymph node hyperplasia, angiofollicular lymph node hyperplasia) and POEMS syndrome have been frequently associated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/30\">",
"     30",
"    </a>",
"    ]. In one small series, two of three patients with POEMS syndrome were reported with angiofollicular lymph node hyperplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/31\">",
"     31",
"    </a>",
"    ]. Antibodies to human herpesvirus 8 (HHV 8), a virus implicated in the pathogenesis of Castleman's disease, were reported in seven of nine patients with POEMS syndrome and Castleman's disease. Nine of 18 patients had circulating anti-HHV 8 antibodies, while six of seven patients with POEMS syndrome and Castleman's disease had HHV-8 DNA sequences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/51/6970?source=see_link\">",
"     \"Castleman's disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 15 percent of patients with POEMS syndrome also have Castleman's disease, similar to the 19 to 24 percent noted in the two other major series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. This may be an underestimation, since many patients do not undergo lymph node biopsy. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Organomegaly'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one study, 18 cases with acute and chronic renal failure associated with POEMS syndrome were reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/33\">",
"     33",
"    </a>",
"    ]. Prominent glomerular changes manifested by mesangial proliferation and thickening of the capillary wall were seen. There was no difference in IL-1, IL-6, or TNF-alpha levels in four cases of POEMS with renal involvement when compared with those without this feature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another report examined 52 cases of POEMS syndrome with renal pathology described in the literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/35\">",
"     35",
"    </a>",
"    ]. Renal tissue was reviewed in 22 patients. Approximately one-half of the patients had creatinine levels above 1.5",
"    <span class=\"nowrap\">",
"     mg/dL;",
"    </span>",
"    10 percent required dialysis. The major pathologic changes were glomerular and included glomerular enlargement, cellular proliferation, mesangiolysis, and marked swelling of the endothelial mesangial cells. Endarteritis-like lesions were found in the small renal arteries. In one reported case, POEMS syndrome subsequently developed in a patient who presented with light chain deposition disease producing nephrotic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cardiovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both arterial and venous thromboses have been described in POEMS syndrome. Fifteen patients reported in the literature had gangrene, ischemia, myocardial infarction, splenic infarcts, or strokes. Four patients have been reported with POEMS syndrome who had an acute arterial thrombotic event [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/37\">",
"     37",
"    </a>",
"    ]; all had elevated cytokines. In a 31-year-old patient with POEMS, ischemic cardiomyopathy was attributed to inflammation of the coronary arteries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Forty-one thrombotic events occurred in 18 patients reported in the Mayo Clinic series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. These most often consisted of cerebral infarction, myocardial infarction, or Budd-Chiari syndrome. Three patients presented with heart failure and cardiomyopathy which resolved following treatment of POEMS syndrome. Four other patients developed heart failure, which occurred during an exacerbation of POEMS syndrome.",
"   </p>",
"   <p>",
"    Extravascular volume overload was seen in 29 percent of patients. Peripheral edema was found in 24 percent; ascites (7 percent) and pleural effusion (3 percent) were much less common. Pericarditis developed in two patients within a few months of presentation; pericardial effusion was seen in a single patient.",
"   </p>",
"   <p>",
"    Elevation of fibrinogen, fibrinopeptide-A, and thrombin-antithrombin complexes during the active phase has been noted. The endothelium of small vessels stained with antithrombin antibody in two previously untreated patients. More than half of the endoneurial blood vessels had narrowed or closed lumina with thickened basement membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the Mayo Clinic experience, 208 patients were diagnosed with POEMS syndrome between 1973 and 2008, of whom 19 (9.2 percent) developed cerebral infarction at a median age of 53 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/40\">",
"     40",
"    </a>",
"    ]. In the subgroup of 90 patients diagnosed with POEMS syndrome between 2000 and 2008, 9 (10 percent) had a stroke at a median of 23 months (range: 0.5-64 months) after the onset of peripheral neuropathy symptoms, for a five-year risk of stroke of 13.4 percent. None of the stroke events occurred after the successful treatment of the underlying syndrome.",
"   </p>",
"   <p>",
"    On multivariate analysis, bone marrow plasmacytosis and an elevated platelet count were significantly predictive for cerebral infarction, while traditional stroke risk variables (eg, increased age, diabetes mellitus, hypertension, smoking, cardiac arrhythmia) were not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pulmonary involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one small series, two of six patients with POEMS syndrome had pulmonary hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/41\">",
"     41",
"    </a>",
"    ]. Two additional patients with pulmonary hypertension and POEMS syndrome have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/42\">",
"     42",
"    </a>",
"    ]. In a third series, pulmonary hypertension developed in 5 of 20 patients with POEMS syndrome over a 10-year follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/6\">",
"     6",
"    </a>",
"    ]; overproduction of interleukin-1beta, interleukin-6, tumor necrosis factor-alpha, and vascular endothelial growth factor was found in all cases in this latter series.",
"   </p>",
"   <p>",
"    In the Mayo Clinic series of 137 patients with POEMS syndrome, pulmonary manifestations were present in 28 percent, and included pulmonary hypertension, restrictive lung disease, respiratory muscle weakness, and an isolated diminished diffusing capacity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/43\">",
"     43",
"    </a>",
"    ]. Significant radiographic findings such as pleural effusion, elevated diaphragm, and increased cardiac silhouette were seen in 28 percent of patients. Respiratory muscle weakness and cough were associated with a poor prognosis. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Clinical course'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Hematologic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, hepatomegaly, splenomegaly, and lymphadenopathy are commonly seen in POEMS syndrome. These patients may also have a variety of systemic complaints and findings, including fatigue, weight loss, fever, bone and joint pain, and an elevated erythrocyte sedimentation rate, which might otherwise suggest the presence of a malignant disorder (eg, non-Hodgkin lymphoma, multiple myeloma), a collagen-vascular disorder (eg, lupus erythematosus), or systemic infection (eg, tuberculosis).",
"   </p>",
"   <p>",
"    Anemia (hemoglobin concentration &lt;11",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    is present in &lt;5 percent of patients, while a hemoglobin &gt;16",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (eg, polycythemia) is seen in approximately 15 percent. Blood volume studies, erythropoietin levels, and reticulocyte counts have not been routinely obtained for evaluating elevated hemoglobin levels.",
"   </p>",
"   <p>",
"    The total white blood cell count and platelet count are elevated (ie, &gt;10,500 and",
"    <span class=\"nowrap\">",
"     &gt;450,000/microL,",
"    </span>",
"    respectively) in approximately 20 and 50 percent of our patients, respectively.",
"   </p>",
"   <p>",
"    Bone marrow examination shows monotypic plasma cells (usually lambda) in about two-thirds of patients, typically in a background of increased polytypic plasma cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/44\">",
"     44",
"    </a>",
"    ]. In about half of the patients, lymphoid aggregates surrounded by a rim of plasma cells can be seen. Megakaryocyte hyperplasia and clusters are also frequent. The constellation of lambda-restricted monoclonal gammopathy, plasma cell rimming around lymphoid aggregates, and megakaryocyte hyperplasia may be highly suggestive of this diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lymph node biopsies are most often read as showing either Castleman's disease or reactive changes. Criteria for the diagnosis of multiple myeloma are not met in any patient (eg, multiple bone fractures, progressive bone marrow failure, or hypercalcemia). No patients in our series died of typical multiple myeloma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other signs and symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other findings commonly seen in POEMS syndrome include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased cerebrospinal fluid protein (&gt;50",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      &mdash; 100 percent",
"     </li>",
"     <li>",
"      Weight loss (&gt;10 pounds) &mdash; 37 percent",
"     </li>",
"     <li>",
"      Fatigue &mdash; 31 percent",
"     </li>",
"     <li>",
"      Papilledema &mdash; 29 percent",
"     </li>",
"     <li>",
"      Edema, ascites, pleural effusion &mdash; 29 percent",
"     </li>",
"     <li>",
"      Clubbing &mdash; 5 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the three major series of patients with POEMS syndrome, all presented with polyneuropathy and 75 to 100 percent had initial evidence for a monoclonal plasma cell disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1,20,21\">",
"     1,20,21",
"    </a>",
"    ]. The immunoglobulin light chain type in POEMS syndrome is almost always lambda. The other three key features defining this syndrome (organomegaly, endocrinopathy, skin changes) were variably met (",
"    <a class=\"graphic graphic_table graphicRef66534 \" href=\"mobipreview.htm?26/5/26716\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Mayo Clinic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a series of 99 patients at the Mayo Clinic, only 29 had all five of the originally described features of this syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. On the basis of these observations, the current Mayo Clinic criteria for POEMS syndrome are based on five major (two of them mandatory) and six minor criteria (",
"    <a class=\"graphic graphic_table graphicRef64782 \" href=\"mobipreview.htm?11/20/11596\">",
"     table 2",
"    </a>",
"    ). The diagnosis of POEMS syndrome requires the presence of at least three major criteria (polyneuropathy, monoclonal plasma cell disorder plus any one of the following three: osteosclerotic myeloma, Castleman&rsquo;s disease, or elevated serum or plasma VEGF levels at least three to four times the upper limit of normal), along with the presence of at least one of the six minor criteria (excluding diabetes mellitus or hypothyroidism) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/45\">",
"     45",
"    </a>",
"    ]. &rdquo;Atypical&rdquo; cases (eg, without polyneuropathy or without a monoclonal paraprotein) have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/46-48\">",
"     46-48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The absence of either osteosclerotic myeloma or Castleman's disease should make the diagnosis of POEMS syndrome suspect. Not every patient who meets the above criteria will have POEMS syndrome; the abnormal features should have a temporal relationship to each other and no other attributable cause. Elevations in plasma or serum levels of vascular endothelial growth factor, thrombocytosis, and polycythemia are common features of the syndrome and are helpful when the diagnosis is difficult. (See",
"    <a class=\"local\" href=\"#H614257969\">",
"     'Vascular endothelial growth factor (VEGF) levels'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Diagnostic workup",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of POEMS syndrome depends on the demonstration of a monoclonal immunoglobulin in the serum or urine, or increased numbers of monoclonal plasma cells in a biopsy specimen from the osteosclerotic lesion or the bone marrow. The M-protein in the serum and urine is almost always present in a low concentration (usually less than 2.0",
"    <span class=\"nowrap\">",
"     g/dL),",
"    </span>",
"    and may be easily overlooked unless immunofixation is performed on both serum and a 24-hour urine collection. In almost all patients the light chain type is lambda. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/58/10154?source=see_link\">",
"     \"Recognition of monoclonal proteins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A metastatic bone survey must be done in a search for osteosclerotic lesions. These lesions can be subtle and easily confused with benign bony sclerosis, fibrous dysplasia, or a vertebral hemangioma. Osteolytic lesions may have a sclerotic rim, which is a helpful diagnostic finding.",
"   </p>",
"   <p>",
"    As in any complex illness, a detailed physical examination is critical, with emphasis on the fundoscopic examination for papilledema, evaluation for organomegaly, examination of the skin, and evaluation for the presence of peripheral edema, pleural or pericardial effusion, ascites, clubbing, heart failure, and cardiomyopathy.",
"   </p>",
"   <p>",
"    If respiratory symptoms are present, pulmonary function testing and echocardiography should be performed. Similarly, a thorough endocrine evaluation may be appropriate in patients with signs and symptoms suggestive of hypogonadism, hypothyroidism, or adrenal disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of conditions are associated with a plasma cell disorder and polyneuropathy, with or without osteosclerotic bone lesions, and need to be distinguished from POEMS syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/49-52\">",
"     49-52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37304?source=see_link&amp;anchor=H5#H5\">",
"     \"Paraneoplastic syndromes affecting peripheral nerve and muscle\", section on 'Association with plasma cell dyscrasias'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Multiple myeloma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyneuropathy is uncommon in classical multiple myeloma, and when present is usually due to the presence of amyloidosis. The presence of anemia, hypercalcemia, renal failure, pathologic fractures, and a high percent of plasma cells in the bone marrow all serve to distinguish classical multiple myeloma from POEMS syndrome. However, this distinction is less easily made in patients with smoldering myeloma or low cell mass myeloma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In rare instances, multiple myeloma may be associated with the presence of diffuse osteosclerotic bone disease in areas of active hematopoiesis, different from the focal sclerotic lesions seen in POEMS. Such patients have the typical clinical and laboratory features of multiple myeloma and do not have the other characteristics of POEMS syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Solitary plasmacytoma of bone",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, patients with solitary plasmacytoma of bone (SPB) have only a single osteolytic bone lesion, whereas in POEMS syndrome the bone lesions are osteosclerotic. Biopsy of the bone lesion shows infiltration with monoclonal plasma cells in both disorders. Systemic signs and symptoms, such as anemia, hypercalcemia, and renal insufficiency are absent in SPB. The presence of an osteoblastic component to the bone lesion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other minor criteria for POEMS (",
"    <a class=\"graphic graphic_table graphicRef64782 \" href=\"mobipreview.htm?11/20/11596\">",
"     table 2",
"    </a>",
"    ) should distinguish patients with POEMS from those with SPB. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/31/44535?source=see_link\">",
"     \"Diagnosis and management of solitary plasmacytoma of bone\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Occasionally, distinguishing SPB from POEMS syndrome may not be straightforward. In one publication, four patients with POEMS syndrome had a violaceous skin patch overlying a solitary plasmacytoma of bone along with enlarged regional lymph nodes. One patient had POEMS syndrome while another patient developed POEMS syndrome after excision of the plasmacytoma. These authors and others suggested the term \"AESOP\" syndrome for this combination of findings (",
"    <strong>",
"     a",
"    </strong>",
"    denopathy and",
"    <strong>",
"     e",
"    </strong>",
"    xtensive",
"    <strong>",
"     s",
"    </strong>",
"    kin patch",
"    <strong>",
"     o",
"    </strong>",
"    verlying a",
"    <strong>",
"     p",
"    </strong>",
"    lasmacytoma) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Monoclonal gammopathy of undetermined significance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monoclonal gammopathy of undetermined significance (MGUS) is classically associated with a plasma cell disorder in the absence of other systemic findings. Polyneuropathy may be seen in patients with MGUS, often associated with an antibody reactive against neural antigens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. The presence of at least one other minor criterion (",
"    <a class=\"graphic graphic_table graphicRef64782 \" href=\"mobipreview.htm?11/20/11596\">",
"     table 2",
"    </a>",
"    ) should serve to distinguish POEMS from MGUS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15290?source=see_link\">",
"     \"Diagnosis of monoclonal gammopathy of undetermined significance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Waldenstrom macroglobulinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Waldenstrom macroglobulinemia (WM) is lymphoplasmacytic lymphoma with the additional presence of an IgM monoclonal gammopathy, and may be complicated by polyneuropathy. In patients with WM there is infiltration of the bone marrow",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lymph nodes with abnormal lymphoplasmacytic cells. These abnormal cellular infiltrates along with absence of other minor criteria for POEMS (",
"    <a class=\"graphic graphic_table graphicRef64782 \" href=\"mobipreview.htm?11/20/11596\">",
"     table 2",
"    </a>",
"    ) should serve to distinguish WM from POEMS. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/47/762?source=see_link&amp;anchor=H21#H21\">",
"     \"Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr&ouml;m macroglobulinemia\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Primary amyloidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary (AL) amyloidosis is a plasma cell disorder often associated with monoclonal gammopathy, skin lesions, and polyneuropathy. The diagnosis of AL amyloidosis is made by biopsy of an involved tissue (fat aspirate or biopsy, bone marrow, GI tract, kidney, heart) showing the presence of typical amyloid fibrils, which are not seen in patients with POEMS syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/15/7418?source=see_link\">",
"     \"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/62/35815?source=see_link\">",
"     \"Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Cryoglobulinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mixed cryoglobulinemia (Type II) may be associated with peripheral neuropathy and the presence of a monoclonal gammopathy. It is most often associated with an underlying lymphoma, viral infection (eg, hepatitis C virus, HIV), or a chronic inflammatory state, such as a connective tissue disease. The diagnosis rests principally in the laboratory demonstration of serum cryoglobulins in association with characteristic clinical signs and symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/63/22522?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of cryoglobulins and cryoglobulinemia\", section on 'Types II and III CG'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     CLINICAL COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The course of POEMS syndrome is chronic; patients survive three times longer compared with multiple myeloma. In one study, the only factors predictive of the development of additional POEMS features on univariate analysis were a serum M-protein &gt;1",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    the presence of monoclonal light chains in the urine, and the absence of radiation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/58\">",
"     58",
"    </a>",
"    ]. On multivariate analysis only the presence of a urinary monoclonal protein was predictive of the development of additional features of the POEMS syndrome.",
"   </p>",
"   <p>",
"    The natural history is one of progressive peripheral neuropathy until the patient is bedridden. Death usually occurs from inanition or a terminal bronchopneumonia. The most commonly identified causes of death in our series were cardiorespiratory failure and infection. None of our patients died of classic myeloma with progressive bone marrow failure, pathologic fractures, or hypercalcemia. Those patients who died of renal failure had coexistent ascites and a capillary leak-like syndrome. Light chain deposition was not observed.",
"   </p>",
"   <p>",
"    Overall median survival was 13.7 years in the Mayo Clinic series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ], while those with clubbing or extravascular volume overload had median survivals of 2.6 and 6.6 years, respectively. Survival was not related to the number of minor criteria present at the time of diagnosis. Patients who received radiation therapy with a good response to treatment had superior survival. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Radiation therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no standard treatment for POEMS syndrome and no randomized controlled clinical trials of treatment exist in the available literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. However, approximately 75 percent of patients have some response to therapy, as discussed below. In general, the mode of therapy is based on whether the patient has limited or widespread sclerotic bone lesions, with radiation therapy employed for those with limited disease, and therapy similar to multiple myeloma for those with widespread bone lesions. Hematopoietic cell transplantation should be considered for patients with rapidly progressive neuropathy and also in younger patients with widespread osteosclerotic lesions. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Hematopoietic cell transplantation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single or multiple osteosclerotic lesions in a limited area should be treated with radiation in a dose of 40 to 50 Gy. Following such treatment, systemic and skin symptoms tend to respond within one month. More than 50 percent of patients treated with radiation showed substantial improvement of the neuropathy, although the improvement in some patients was not apparent for six months or longer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"     1",
"    </a>",
"    ]. We have seen patients who have continued to improve for two to three years following radiation therapy. Of the 13 patients who did not respond to radiation, nine received &lt;40 Gy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient has widespread osteosclerotic lesions, systemic therapy is necessary, although experience is limited to determine the optimal regimen.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One option is",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/54/22376?source=see_link\">",
"       melphalan",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      . In a Mayo Clinic study, melphalan plus prednisone (MP) was given to 48 patients, with improvement noted in 44 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"       1",
"      </a>",
"      ]. In this study, single agent corticosteroids produced responses in 15 percent of patients, while treatments such as plasmapheresis, immunosuppressive agents (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      ), and intravenous immunoglobulin did not appear to have any benefit.",
"     </li>",
"     <li>",
"      In a separate series of 31 newly diagnosed patients, oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/54/22376?source=see_link\">",
"       melphalan",
"      </a>",
"      (10",
"      <span class=\"nowrap\">",
"       mg/m2)",
"      </span>",
"      plus oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      (40",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      were given on days 1 through 4 of every 28-day cycle, for a total of 12 planned cycles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/61\">",
"       61",
"      </a>",
"      ]. Complete and partial remissions were noted in 39 and 42 percent, respectively. Neurologic improvement was noted in 77 percent at three months, increasing to 100 percent at a median time of 12 months (range: 3 to 15 months). As a result we prefer the melphalan plus dexamethasone regimen over MP.",
"     </li>",
"     <li>",
"      The role of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/25/16793?source=see_link\">",
"       lenalidomide",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/62/29673?source=see_link\">",
"       thalidomide",
"      </a>",
"      in the treatment of POEMS syndrome is not clear, but these agents can be used in a manner similar to that employed in multiple myeloma in selected patients with multiple osteosclerotic lesions or neuropathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/62-64\">",
"       62-64",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/63/11257?source=see_link\">",
"       Bortezomib",
"      </a>",
"      may be considered in special circumstances, but one must be aware of its neurotoxicity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Hematopoietic cell transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autologous hematopoietic cell transplantation (HCT) following high-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/54/22376?source=see_link\">",
"     melphalan",
"    </a>",
"    is an important consideration for younger patients with multiple osteosclerotic lesions. If HCT is contemplated, stem cells should be collected",
"    <strong>",
"     before",
"    </strong>",
"    the patient is exposed to alkylating agents (eg, melphalan). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/47/31482?source=see_link&amp;anchor=H2#H2\">",
"     \"Autologous hematopoietic cell transplantation in multiple myeloma\", section on 'Initial chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fifty-nine patients with POEMS syndrome have undergone autologous HCT using peripheral blood stem cells at the Mayo Clinic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/58\">",
"     58",
"    </a>",
"    ]. Clinical improvement was nearly universal in these patients with five-year overall and progression-free survivals of 94 and 75 percent, respectively. Other reports of autologous HCT in POEMS have also described clinical improvement, with often dramatic neurologic improvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/14,65-67\">",
"     14,65-67",
"    </a>",
"    ]. These studies illustrate that for transplant eligible patients, autologous HCT is one of the most important treatment advances in the treatment of POEMS syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Other treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of agents with",
"    <span class=\"nowrap\">",
"     anticytokine/anti-VEGF",
"    </span>",
"    activity may be effective in ameliorating some or all of the signs and symptoms of this disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/5\">",
"     5",
"    </a>",
"    ], although case reports of successful treatment with such agents are anecdotal at this time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/14/35049/abstract/62,63,68-73\">",
"     62,63,68-73",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6653014\">",
"     'Pathophysiology'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/22/16746?source=see_link\">",
"     \"Cytokine networks in rheumatic diseases: Implications for therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of POEMS syndrome is unknown, although chronic overproduction of pro-inflammatory and other cytokines appears to be a major feature of this disorder. (See",
"    <a class=\"local\" href=\"#H6653014\">",
"     'Pathophysiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    POEMS syndrome is characterized by the presence of the following elements (",
"    <a class=\"graphic graphic_table graphicRef66534 \" href=\"mobipreview.htm?26/5/26716\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Polyneuropathy",
"     </li>",
"     <li>",
"      Organomegaly",
"     </li>",
"     <li>",
"      Endocrinopathy",
"     </li>",
"     <li>",
"      Monoclonal protein",
"     </li>",
"     <li>",
"      Skin changes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This condition should be suspected in a patient with polyneuropathy and evidence for a monoclonal plasma cell disorder (",
"    <a class=\"graphic graphic_table graphicRef66534 \" href=\"mobipreview.htm?26/5/26716\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of POEMS syndrome requires the presence of at least three major criteria (ie, polyneuropathy plus monoclonal plasma cell disorder plus any one of the following three: osteosclerotic bone lesion(s), Castleman&rsquo;s disease, or elevated serum or plasma VEGF levels), along with the presence of at least one of the six minor criteria (",
"      <a class=\"graphic graphic_table graphicRef64782 \" href=\"mobipreview.htm?11/20/11596\">",
"       table 2",
"      </a>",
"      ). The absence of either osteosclerotic myeloma or Castleman's disease should make the diagnosis of POEMS syndrome suspect. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of POEMS syndrome includes the various clonal plasma cell (or lymphoplasmacytic) disorders and cryoglobulinemia. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no standard treatment for this disorder and there have been no randomized controlled clinical trials of treatment for POEMS syndrome. However, approximately 75 percent of treated patients have had some response to therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We recommend that symptomatic patients with a single osteosclerotic lesion (or multiple lesions in a limited area) be treated with radiation in a dose of 40 to 50 Gy rather than no treatment or systemic therapy (",
"    <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"     Grade 1C",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Radiation therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If the patient is symptomatic and has widespread osteosclerotic lesions or severe symptoms, we recommend systemic therapy similar to that employed in multiple myeloma (eg, chemotherapy, hematopoietic cell transplantation (HCT)) over no treatment or radiation therapy alone, although experience with these modalities is limited (",
"    <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"     Grade 1C",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The best chemotherapeutic responses to date have been seen following treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/54/22376?source=see_link\">",
"     melphalan",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    , although the role of novel agents used effectively in multiple myeloma (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/25/16793?source=see_link\">",
"     lenalidomide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/63/11257?source=see_link\">",
"     bortezomib",
"    </a>",
"    ) has not been well studied. (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Chemotherapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We suggest that autologous HCT following high-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/54/22376?source=see_link\">",
"     melphalan",
"    </a>",
"    be considered for younger transplant-eligible patients with widespread osteosclerotic lesions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severe symptoms, especially progressive neuropathy (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Hematopoietic cell transplantation'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/1\">",
"      Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003; 101:2496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/2\">",
"      Scheinker I. Myelom und Nervensystem: &uuml;ber eine bisher nicht beschriebene mit eigent&uuml;mlichen Hautver&auml;nderungen einhergehende Polyneuritis bei einem plasmazellul&auml;ren myelom des Sternums. Dtsch Z Nervenheilkd 1938; 147:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/3\">",
"      CROW RS. Peripheral neuritis in myelomatosis. Br Med J 1956; 2:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/4\">",
"      Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) 1980; 59:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/5\">",
"      Gherardi RK, B&eacute;lec L, Soubrier M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 1996; 87:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/6\">",
"      Lesprit P, Godeau B, Authier FJ, et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med 1998; 157:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/7\">",
"      Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 2005; 128:1911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/8\">",
"      Hitoshi S, Suzuki K, Sakuta M. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease. Intern Med 1994; 33:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/9\">",
"      Shikama N, Isono A, Otsuka Y, et al. A case of POEMS syndrome with high concentrations of interleukin-6 in pericardial fluid. J Intern Med 2001; 250:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/10\">",
"      Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 2000; 23:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/11\">",
"      Endo I, Mitsui T, Nishino M, et al. Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome. Intern Med 2002; 41:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/12\">",
"      Shinde A, Matsumae H, Maruyama A, et al. [A patient with Crow-Fukase syndrome associated with pulmonary plasmacytoma]. Rinsho Shinkeigaku 2001; 41:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/13\">",
"      Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998; 21:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/14\">",
"      Kuwabara S, Misawa S, Kanai K, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006; 66:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/15\">",
"      Michizono K, Umehara F, Hashiguchi T, et al. Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome. Neurology 2001; 56:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/16\">",
"      Kelly JJ Jr, Kyle RA, Miles JM, Dyck PJ. Osteosclerotic myeloma and peripheral neuropathy. Neurology 1983; 33:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/17\">",
"      Sung JY, Kuwabara S, Ogawara K, et al. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve 2002; 26:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/18\">",
"      Ono K, Ito M, Hotchi M, et al. Polyclonal plasma cell proliferation with systemic capillary hemangiomatosis, endocrine disturbance, and peripheral neuropathy. Acta Pathol Jpn 1985; 35:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/19\">",
"      Adams D, Said G. Ultrastructural characterisation of the M protein in nerve biopsy of patients with POEMS syndrome. J Neurol Neurosurg Psychiatry 1998; 64:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/20\">",
"      Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984; 34:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/21\">",
"      Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med 1994; 97:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/22\">",
"      Gandhi GY, Basu R, Dispenzieri A, et al. Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc 2007; 82:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/23\">",
"      Shichiri M, Iwashina M, Imai T, et al. Abnormal FSH hypersecretion as an endocrinological manifestation of POEMS syndrome. Endocr J 1998; 45:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/24\">",
"      Abe D, Nakaseko C, Takeuchi M, et al. Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome. Blood 2008; 112:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/25\">",
"      Kanai K, Sawai S, Sogawa K, et al. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology 2012; 79:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/26\">",
"      Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 1998; 94:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/27\">",
"      D'Souza A, Hayman SR, Buadi F, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood 2011; 118:4663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/28\">",
"      Perniciaro C. POEMS syndrome. Semin Dermatol 1995; 14:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/29\">",
"      Tsai CY, Lai CH, Chan HL. Glomeruloid hemangioma--a specific cutaneous marker of POEMS syndrome. Int J Dermatol 2001; 40:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/30\">",
"      Bitter MA, Komaiko W, Franklin WA. Giant lymph node hyperplasia with osteoblastic bone lesions and the POEMS (Takatsuki's) syndrome. Cancer 1985; 56:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/31\">",
"      Gherardi R, Baudrimont M, Kujas M, et al. Pathological findings in three non-Japanese patients with the POEMS syndrome. Virchows Arch A Pathol Anat Histopathol 1988; 413:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/32\">",
"      B&eacute;lec L, Mohamed AS, Authier FJ, et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood 1999; 93:3643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/33\">",
"      Modesto-Segonds A, Rey JP, Orfila C, et al. Renal involvement in POEMS syndrome. Clin Nephrol 1995; 43:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/34\">",
"      Soubrier M, Sauron C, Souweine B, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis 1999; 34:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/35\">",
"      Nakamoto Y, Imai H, Yasuda T, et al. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant 1999; 14:2370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/36\">",
"      Lambotte O, D&uuml;rrbach A, Ammor M, et al. Association of a POEMS syndrome and light chain deposit disease: first case report. Clin Nephrol 2001; 55:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/37\">",
"      Lesprit P, Authier FJ, Gherardi R, et al. Acute arterial obliteration: a new feature of the POEMS syndrome? Medicine (Baltimore) 1996; 75:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/38\">",
"      Ichikawa Y, Nakata T, Ohhata J, et al. Crow-Fukase syndrome with ischemic cardiomyopathy. Intern Med 2001; 40:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/39\">",
"      Saida K, Kawakami H, Ohta M, Iwamura K. Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle Nerve 1997; 20:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/40\">",
"      Dupont SA, Dispenzieri A, Mauermann ML, et al. Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics. Neurology 2009; 73:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/41\">",
"      Rose C, Zandecki M, Copin MC, et al. POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Leukemia 1997; 11:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/42\">",
"      Ribadeau-Dumas S, Tillie-Leblond I, Rose C, et al. Pulmonary hypertension associated with POEMS syndrome. Eur Respir J 1996; 9:1760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/43\">",
"      Allam JS, Kennedy CC, Aksamit TR, Dispenzieri A. Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients. Chest 2008; 133:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/44\">",
"      Dao LN, Hanson CA, Dispenzieri A, et al. Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood 2011; 117:6438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/45\">",
"      Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/46\">",
"      Morizane R, Sasamura H, Minakuchi H, et al. A case of atypical POEMS syndrome without polyneuropathy. Eur J Haematol 2008; 80:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/47\">",
"      Ofran Y, Yishay O, Elinav E, Eran E. POEMS syndrome: failure of newly suggested diagnostic criteria to anticipate the development of the syndrome. Am J Hematol 2005; 79:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/48\">",
"      Charli-Joseph Y, Fern&aacute;ndez-S&aacute;nchez M, Saeb-Lima M, Orozco-Topete R. POEMS syndrome: are current diagnostic criteria too exclusive? J Am Acad Dermatol 2011; 65:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/49\">",
"      Eurelings M, Notermans NC, Van de Donk NW, Lokhorst HM. Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy. Muscle Nerve 2001; 24:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/50\">",
"      Vital A. Paraproteinemic neuropathies. Brain Pathol 2001; 11:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/51\">",
"      Wicklund MP, Kissel JT. Paraproteinemic Neuropathy. Curr Treat Options Neurol 2001; 3:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/52\">",
"      Gorson KC. Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS). J Clin Apher 1999; 14:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/53\">",
"      Lacy MQ, Gertz MA, Hanson CA, et al. Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome). Am J Hematol 1997; 56:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/54\">",
"      Lipsker D, Rondeau M, Massard G, Grosshans E. The AESOP (adenopathy and extensive skin patch overlying a plasmacytoma) syndrome: report of 4 cases of a new syndrome revealing POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes) syndrome at a curable stage. Medicine (Baltimore) 2003; 82:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/55\">",
"      N&eacute;el A, Hello M, Barbarot S, et al. Skin patch, polyneuropathy, and paraproteinemia. Am J Med 2012; 125:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/56\">",
"      Nobile-Orazio E, Casellato C, Di Troia A. Neuropathies associated with IgG and IgA monoclonal gammopathy. Rev Neurol (Paris) 2002; 158:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/57\">",
"      Fisher MA, Wilson JR. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size. Neurol Clin Neurophysiol 2002; 2002:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/58\">",
"      D'Souza A, Lacy M, Gertz M, et al. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience. Blood 2012; 120:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/59\">",
"      Kuwabara S, Dispenzieri A, Arimura K, et al. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database Syst Rev 2012; :CD006828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/60\">",
"      Dispenzieri A. How I treat POEMS syndrome. Blood 2012; 119:5650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/61\">",
"      Li J, Zhang W, Jiao L, et al. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 2011; 117:6445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/62\">",
"      Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 2007; 110:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/63\">",
"      Kuwabara S, Misawa S, Kanai K, et al. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. J Neurol Neurosurg Psychiatry 2008; 79:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/64\">",
"      Tom&aacute;s JF, Giraldo P, Lecumberri R, Nistal S. POEMS syndrome with severe neurological damage clinically recovered with lenalidomide. Haematologica 2012; 97:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/65\">",
"      Jaccard A, Royer B, Bordessoule D, et al. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 2002; 99:3057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/66\">",
"      Rovira M, Carreras E, Blad&eacute; J, et al. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol 2001; 115:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/67\">",
"      Kuwabara S, Misawa S, Kanai K, et al. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome. Neurology 2008; 71:1691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/68\">",
"      Authier FJ, Belec L, Levy Y, et al. All-trans-retinoic acid in POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines. Arthritis Rheum 1996; 39:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/69\">",
"      Coto V, Auletta M, Oliviero U, et al. POEMS syndrome: an Italian case with diagnostic and therapeutic implications. Ann Ital Med Int 1991; 6:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/70\">",
"      Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005; 106:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/71\">",
"      Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood 2006; 107:4972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/72\">",
"      Dietrich PY, Duchosal MA. Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome. Ann Oncol 2008; 19:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/14/35049/abstract/73\">",
"      Ropper AH, Raje NS, Lawrimore TM, et al. Case records of the Massachusetts General Hospital. Case 7-2010. A 49-year-old man with peripheral neuropathy and ascites. N Engl J Med 2010; 362:929.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6662 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-285D26EE14-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35049=[""].join("\n");
var outline_f34_14_35049=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORICAL BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6653014\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Peripheral neuropathy and CNS involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Organomegaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Endocrine abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Monoclonal plasma cell disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H614257969\">",
"      Vascular endothelial growth factor (VEGF) levels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Skin changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Bone lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Castleman's disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pulmonary involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Hematologic features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other signs and symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Mayo Clinic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Diagnostic workup",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Solitary plasmacytoma of bone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Monoclonal gammopathy of undetermined significance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Waldenstrom macroglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Primary amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Cryoglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      CLINICAL COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Other treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/6662\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/6662|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/5/26716\" title=\"table 1\">",
"      Clinical features of POEMS syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/20/11596\" title=\"table 2\">",
"      Diagnostic criteria POEMS syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/47/31482?source=related_link\">",
"      Autologous hematopoietic cell transplantation in multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/51/6970?source=related_link\">",
"      Castleman's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=related_link\">",
"      Clinical features, laboratory manifestations, and diagnosis of multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/15/7418?source=related_link\">",
"      Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/22/16746?source=related_link\">",
"      Cytokine networks in rheumatic diseases: Implications for therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/31/44535?source=related_link\">",
"      Diagnosis and management of solitary plasmacytoma of bone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15290?source=related_link\">",
"      Diagnosis of monoclonal gammopathy of undetermined significance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/47/762?source=related_link\">",
"      Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr&ouml;m macroglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/60/1994?source=related_link\">",
"      Overview of angiogenesis inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/63/22522?source=related_link\">",
"      Overview of cryoglobulins and cryoglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37304?source=related_link\">",
"      Paraneoplastic syndromes affecting peripheral nerve and muscle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/62/35815?source=related_link\">",
"      Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/58/10154?source=related_link\">",
"      Recognition of monoclonal proteins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_14_35050="Bullous pemphigoid multiple lesions";
var content_f34_14_35050=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72866%7EDERM%2F79112%7EDERM%2F78910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72866%7EDERM%2F79112%7EDERM%2F78910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous plaques, bullae, erosions, and crusts are present on the trunk and extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.&nbsp;&nbsp;",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arm skin with tense bullae arising on urticarial plaques and eroded blister bases.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple bullae and erosions arising on erythematous plaques are present in the axilla.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35050=[""].join("\n");
var outline_f34_14_35050=null;
var title_f34_14_35051="Comparison of ileus and small bowel obstruction";
var content_f34_14_35051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comparison of ileus and small bowel obstruction",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Sign or symptom",
"       </td>",
"       <td class=\"subtitle1\">",
"        Ileus",
"       </td>",
"       <td class=\"subtitle1\">",
"        SBO",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal distention",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bowel sounds",
"       </td>",
"       <td>",
"        Usually quiet or absent",
"       </td>",
"       <td>",
"        May be high-pitched, may be absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obstipation",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"       </td>",
"       <td>",
"        Mild and diffuse",
"       </td>",
"       <td>",
"        Moderate to severe, colicky",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peritoneal signs",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radiography",
"       </td>",
"       <td>",
"        Dilated loops of bowel, paucity of colonic gas",
"       </td>",
"       <td>",
"        Dilated loops of bowel, differential air-fluid levels, paucity of colonic gas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever, tachycardia",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        Should raise suspicion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vomiting",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"       <td>",
"        May be present, may be bilious or feculent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35051=[""].join("\n");
var outline_f34_14_35051=null;
var title_f34_14_35052="Relative radiation doses for spine imaging studies";
var content_f34_14_35052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Relative radiation doses for spine imaging studies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Procedure",
"       </td>",
"       <td class=\"subtitle1\">",
"        Modality",
"       </td>",
"       <td class=\"subtitle1\">",
"        Average effective dose (mSv)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of chest x-rays (PA/lateral) with equivalent radiation dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skull radiograph",
"       </td>",
"       <td>",
"        Conventional radiography",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical spine radiograph",
"       </td>",
"       <td>",
"        Conventional radiography",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thoracic spine radiograph",
"       </td>",
"       <td>",
"        Conventional radiography",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lumbar spine radiograph",
"       </td>",
"       <td>",
"        Conventional radiography",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT head",
"       </td>",
"       <td>",
"        Computed tomography",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT neck",
"       </td>",
"       <td>",
"        Computed tomography",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angiogram head/neck",
"       </td>",
"       <td>",
"        Conventional fluoroscopy or interventional radiology",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT spine",
"       </td>",
"       <td>",
"        Computed tomography",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brain perfusion",
"       </td>",
"       <td>",
"        Nuclear medicine",
"       </td>",
"       <td>",
"        6.9",
"       </td>",
"       <td>",
"        69",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT angiogram (rule out stroke)",
"       </td>",
"       <td>",
"        Computed tomography",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        140",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brain PET",
"       </td>",
"       <td>",
"        Nuclear medicine",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        140",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PET: positron-emission tomography.",
"     <br>",
"      * PA and lateral chest radiograph = .1 mSv.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Mettler FA, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008; 248:254.",
"       </li>",
"       <li>",
"        Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169:2078.",
"       </li>",
"       <li>",
"        Shrimpton PC, Hillier MC, Lewis MA, Dunn M. National survey of doses from CT in the UK: 2003. Br J Radiol 2006; 79:968.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35052=[""].join("\n");
var outline_f34_14_35052=null;
var title_f34_14_35053="Incidence pertussis US 1990 to 2011";
var content_f34_14_35053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Incidence pertussis, United States 1990 to 2011",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 367px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Centers for Disease Control and Prevention, National Notifiable Diseases Surveillance System, 2011. Available at",
"     <a href=\"file://www.cdc.gov/pertussis/surv-reporting.html\" style=\"font-style: italic;\" target=\"_blank\">",
"      www.cdc.gov/pertussis/surv-reporting.html",
"     </a>",
"     (Accessed on January 29, 2013).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35053=[""].join("\n");
var outline_f34_14_35053=null;
var title_f34_14_35054="Posterior pelvic tilt";
var content_f34_14_35054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F53897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F53897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 479px\">",
"   <div class=\"ttl\">",
"    Posterior pelvic tilt",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 459px; height: 180px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAC0AcsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiuP8X/Evwb4PkaHxD4hsbW5R1je2RjNOhZdw3RRhnUEc5IA5HPIzyrftEfDMXUcQ1+Vo2RmMwsbjYhBUBSNm7J3EjAI+U5I4BAPWqKyvDPiLR/FGlR6l4e1G21CyfA8yBw21iobaw6qwDDKsARnkCtWgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKxfF/irRPB2jNqviXUIrCxV1j8xwzFnboqqoLMepwAeAT0BNfN8vjX4o/G2/vrb4dp/wj3haGYxG/aTyJDwHUSSjLbvl+7CPlEgDlgQxAPVfiV8bfD3hGb+zNK/4qPxM8y28elWDlm3lyhV3VWCsCpGzBfJUbQDkc14T0z4z+NpJL3xVr0Xg/RLtADYWNrH9q2FUzsLBnhLAv8zOXRx9wDGOw+FHwb8M/DqFZrSL+0daOGbUruNTIh2bWEIx+6U5fgEkhsMzADHpVAHP+DvBvh3wZYNZ+GNJttPifHmNGC0kuCxG+RiWfG5sbicA4GBWrqum2Or2EtjqtlbX1lLjzLe5iWWN8EEZVgQcEA/UCrdFAHivjjwHqngrVT4y+EsH2Z18r+1/DtoipDqMEbAnyk2kJLtBHyrkhiV+YkSeleBfF+j+OPDlvrfh+4860l+V0biSCQY3RyL/CwyOOhBBBIIJ6CvGodVg+F/xgn0e9SVfD/je6F5YSIAwt9RJVJ0YZLkSExNu4VSwAGNzAA9looooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArzr4nfFvQPAivakS6vruyRxpdgQ8sYSIyl5v+eUe3BLEE7SWCsAccf8c/iXfQX9z4O8JyXNper5Uep6pFCzyW3nDMVvaoMGW5lB+UKRgZOV2u8WV8JvgLG01zrfxLsvtV3Jey3Nrp11MlxJGWdSXuZ0A+0Mdg+U5TBYlcyMFAOf0T4deK/jbqtvrnxHv7mDQIvOaxls2WJLmF2/d/ZoXTdGvyljLKC7oYhjjcPprw/o2neHtGtNJ0W0is9OtU8uGCMcKOp5PJJJJJOSSSSSSa0KKACiiigArhfh18RIPGev8AjDSF0+WzufDmoNZuxkEiTpvdVcHAIJMT5XBxxycnGf8AHT4jR+AvDcUFo3/FQ6xvtdM3MkccUnAM0kkn7tVQup+bgkgHC7mXyX9iK2ntJPGsd1DLDIU0+QLIhUlHWdkbB7FWDA9wQe9AH1JXNfEXwfp3jrwjf6HqkcRWdCYJnTebabBCSqAQcqT0yMjKngkV0tFAHnXwN8R6jrHhE6T4njlg8VaA40/U4Z2zISADHMfmYsHTB8w8Owcrxg16LXkvjaBPAPxL07x1btLHo+tOmleId0jGOMkBba6IJCIEKhGdjgK3yruYk+tUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFU9Gvl1TSLHUI0MaXUEc6o3JUMobB/Op7u5gs7Sa6vJooLaFGklllcKkaAZLMTwAACSTSTvqVKLi3GW6Ja4XSPi14H1nWRpOk69Fe6iboWiw28EshdzuOVITDRgIxMgyijBLAEZ8K8aePfGXxs1/UPC3wsjlh8LxoIL28fEXno7gF5HYbkjODiNfnZQ+QclF7r9l3wNa+EofGC3Npu1qz1mbS/tssJjkktkSJ0KqSdqvu38feBXJICkMk9Qh8E6KnjafxbPBLda66CGGe4lZxaxbFXy4UPyoDhmJA3Zkk5wxFdLRRQAUUUUAFZXivXrHwv4c1HW9Vk2WVjC00mCoZsDhF3EAsxwqjIySB3qXxBrOneHtGu9W1q7is9OtU8yaeQ8KOg4HJJJAAGSSQACSK8V8M20/xw8XXGv+IYZf8AhXujXRXRLAoRBqkqllNzKGwzgY+6VC/Ns52yhwC38JPBd74p1m9+JXj0RXc+t2rR6Zpc+y4js7CXlVJ24yY224AHyu5bLSMF8q+BGoaj4Z+JPhC01aKxsYwmpeErgTT7n86KY3RwRhQTJcQxLgvuw2Oq19iV8bftQ+DL7wv47PibTbm2sdN1iYXiXENs0b2l7BESFEqKSrStlwQV3OSWA8vfQB9k0Vwvwd+ImnfEbwjb6hazRjVIUSPUrVRtME2OcKST5bEEqcnI4J3BgO6oAyvFeg2Pijw5qOiarHvsr6FoZMBSy5HDruBAZThlODggHtXP/BzWLrWPh9pq6qca1p2/S9SRroXEiXNuxicyOP4m2h+/Djkggnta8qg/4or45pY2/wDyCPG8MtytunSDULZAZZAowqrJGQWb5nZwM4AoA9VooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorgPi5repRWen+FfDE9tB4m8S/aLWzmuJJYlt40hZ5Zg8akhlG0L0O51PIUigC/4m+Jng3wxrNvpOu+IbG01GdxH5JYsYidpHmlQRECHU5faMc5wCR0ulalY6vYRX2lXttfWUufLuLaVZY3wSDhlJBwQR9Qa8wC6B8GLS10rQ9N1fxB4o8S3UzxBmEl3qEygsXnnICrGu8Zb+EMzbT87V5Ven4mfBy1i1yx0rwtbW2v3UVsfDuni6nRbyQM4dYtxCyYXyyIn2HCgKcAgA+r6K+evhf4z+KXxZ0C4vbC/8LeHtOS6a0kvIbOWa7idUR8pHI5jYHcqnceAWI5ArmvCnjLxz8ONK8Sa/qWgeLdf8Mj7JEtx4mv/ALJcW8gULIywv5jbXklGNuQAoBZiCQAfVVFea2Pxu8CXFho93c6pc6fFqvFs99YTxRswIV180p5XyMdrMHKqepxzXpVABRRXP+OvF+j+B/DlxrfiC48m0i+VEXmSeQ52xxr/ABMcHjoACSQASADQ8Qazp3h7RrvVtau4rPTrVPMmnkPCjoOBySSQABkkkAAkiuAb4k+INYtY7zwL8PdX1nTmdlF3f3UOmJMmFKSwrIS7xuGyGKr26nIFTRPBl38RGsfE3xPtZY42RZLPwuzSLb2hWWRklnXeRLMY2UHKoACysnYetUAeQaF8etC1HSp57nQ/Elte2Eywatapp0k39mjaS8srqMCJSrg5w/yE7OK2pvjZ8OYdGg1R/FdibaZzGqIsjTg/N96EKZFHynllA6c8jPotFAHktp8Yb3W7WE+Ffhz4yvbm6RZLVr21SztJUI3bjcFmVQVyQcHccAda0PDPxo8Ka1rsehXv9paBr8kwgj03WbRreZmKhl55UbsgKGYEnAA5XPpVc1488EaB460aTTvEVhFOpRkhuAoE9sWwd0TkEqcqp9DjDAjIoA6WqWparp+loralfWtorfdM8qpu+mTzXjtz8MviN4Y05bL4b/EaX+zkdFhstct45jBGIwuFmKOcAqMIEVQCe4O7B8f+G/ifeWt3q3jO78MXOmWoWSO30wSh7borbNyAlW4ZtzNjHGBkHOrJwg5LodmX0KeJxMKNWVlJ2v8Al+J6z4c8UaHpPw2sNSv9Vs4rPTtOgN3J5obySEUbSBk7s8BcZJ4AJ4rhPE0mt/GyO30TSLC+0b4ezOJb/V72FY59QRGV41tY2ywjb5HEpAz/AMBKOnwo+FmgappNp4g8T6bHqV05Y2sF0N8MUfKkmM/KxbrlgcYQgAjJ9wpUW3TTZeaU4UsZUhTd0m9fz/E5/wAC+ENH8D+HLfRPD9v5NpF8zu3Mk8hxukkb+Jjgc9AAAAAAByuhfbtH+PPiawl+0zabr+mQavA7blhglg2W0kajkMzKYmZhggbAQeDXpVeVfHG0vtN/sHxxZL5v/CL3sdzMkELPcfYpNyXgUElG3IYzyF2CN2388anAeq0VFaXMF5aQ3VnNFPbTIskUsThkkQjIZSOCCCCCKloAK5/x14v0fwP4cuNb8QXHk2kXyoi8yTyHO2ONf4mODx0ABJIAJG3d3MFnaTXV5NFBbQo0kssrhUjQDJZieAAASSa8V0Bp/jF8Q7TxK8d9F8PdAffpKySGEajfo/8Ax87NoYxryBuPVQP4pUABDoXw51j4keJLDxr8VV8m0i3PpvhUqTHbRkqUM5P3mOMuhXJIQNgAxD3WiigArmviL4P07x14Rv8AQ9UjiKzoTBM6bzbTYISVQCDlSemRkZU8EiulooA+JvEGoeI/hl8VLu8utRin8Xaba4F3fGRLbXrLytqF8sv75FUcbirtFjJlT999afDrxhp3jrwjYa5pckRWdAJ4UfebabALxMSAcqT1wMjDDgg1b8X+FdE8Y6M2leJdPiv7FnWTy3LKVdejKykMp6jII4JHQkV8i+Gf7c/Zy+Lkdtrv7/w3qmIHuxvWGaDeP36quf3sWeUIYgMwHDq5APtSvNf2gtPupvh9/bWmRedqXhq9g122iZgI3aBsv5mSCVEZkbAIJIGD2Pf6TqFrq+lWWpafL51leQpcQSbSu+N1DKcEAjII4IBq3QBU0nULXV9KstS0+XzrK8hS4gk2ld8bqGU4IBGQRwQDVuvJfhxqFp4J8e6l8LzFLb2KodU0B5p42328nMsA6OSsvnld25iobJwoLetUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5h8MYH8TeNPEvj+6MTwTO+iaKYpFkT7DBIQ8quhwwlmDMNwyu3hipFaHx+1f+xPg34suvI8/wAyyNnt37ceeRDuzg/d8zdjvjGRnNdppOn2ukaVZabp8Xk2VnClvBHuLbI0UKoySScADkkmgDwX9qbWLnw7rPg3XrS41fS7nTnnS31C206G7gzPsSRDvkG2QRK7KpUh84DDDFcXwP40j8Oar4W8N6laf8JZ4D1PU1Twnrd2ifaLdkYR48txu/dSOEDkIQAxXK7UH0L418PweKvCOr6FdeUsd/ayQCSSISiJyPkk2nGSrYYcjlRyOteX+EPAM1r+z1rXhh/Cf9m61dWU4ls57uO5W6vfJVUuFfeyruZI2AO3Yy8cAMQD1/StNsdIsIrHSrK2sbKLPl29tEsUaZJJwqgAZJJ+pNRa9o2na/pj6drNpFeWMjxyPBKMo5R1ddw7jcqkg8HoQQSK5X4N+KrLxF4L0+1XUJbrW9KtYLPV4rkOtxDdLGBIJQ4DZ3Bxu5BKtySDXVa3relaDapda5qdjpts7iNZbydIUZyCQoZiBnAJx7GgA8QaNp3iHRrvSdatIrzTrpPLmgkHDDqORyCCAQRgggEEECvOv2X9S/tH4JeH9959rntvOtpcy+Y0W2Z9kbc5XEZjwp6KVxxisrxNd+IfinpUkVo3/CK/Dd8y3ms3MwjutSsgpLGKMj9zEdpy0hG5GVsFdyH5w8byeEfHHjC28PfC/wAIy2rFzBBewNJJLe7Idsf7l3VIoyVy8jZbb+8bBDKwB9qeL/G+geE42XVL+I6gUVoNMgYSXl0WbYixQg7nLN8owMZzkgAkc14Z0vVPG2vR+J/Gmm3OnWFhMH0LRLnb+7+UEXk6qxzP8xVUbHlYOAWO6vJfhV+zRqOnyQ6v4n8RX2k6iEJhh0Ofy54Cyj705BGcGRSqgg8EORkV5f8AtCfB/wD4Vnf2N1pVxc3mgX2Y45J1zJBKoBKSMqhTu5ZehIDDHy7iAfelFfPfwG+N+nXPhfTNH8f6jLYayqN9n1DUjtiv4QzgSeaQFBXY0ZLH5mX7zMWA+hKACiiigAooooAKr6haQ39jcWlyu6CeNonX1Vhg1Yoo3Gm4u63K+n2kNhY29pbLtggjWJF9FUYFWKKKNgbcndhXH/Efxbo/hzR5rfVY4r6W6iaMaewDCZGBBDg5Gw8g5HPI5rsK+eviX4NudR+IM0Ghyy311cjzZI5n/wBUxDMVDE9AAOvTeg7isMRUlCN4LU9fJMHh8XiOXEytFK/rbu+iNv4B+LYrGGHwFrcssGp2sCXGkm53f6bZMgYbHY/OyHzFIUABUAUEI2Paq8+8deArnW/CmjRaBqP9k+JdBCS6VqAQHY6x7DG5wT5TjhgODhSQwG08trvxQtf+EB8RaJ4/srbQ/GKaNcPLpN7IVt70GIhTDKrYdZCduxX3gh1527q1imopM8zESjKrKUFZNu3pcqf6d8edV/5ebD4V2U3+1FNr0qN+BWBWHscj+/8A6n3C0toLO0htbOGKC2hRY4ookCpGgGAqgcAAAAAV5f8Asuf8kJ8M/wDb1/6VS16rVGQUUUUAFFFFABXAfGv4c2vxI8Gz6dttotYg/e6feTKT5MmRlSRyFcDaeoHDbSVFd/RQB8l/swfEO68JQzeF/F8f2PRftssUd7d3AjGnXIQu0Eyuw8pX2OVyFy4kADHds+tK8A/au+GUfiDwq/ifRLO2TV9L33F66hI2ubYIN5ZtuXZBGpUFhhd4GSQK0Pg38RNRuPBes2V/NL4i1nSNPGpaa4XZNqto0ZMY4LlplkVoZCoYK4Cku2SQDqvjh4MvfFnhe2uvDojTxVot1HqOkytsB81GBKZdSMMBnBwpZU3HANaHwo8d2vjrw2szf6Prtli31bT3jMUlpcjhwUYkhSwbaSTwCD8ysB0HhTXrHxR4c07W9Kk32V9Cs0eSpZcjlG2kgMpyrDJwQR2rxX4r+A9e0T4j6X4v+EWn3I8RXfmvqVugjSyuIwU3GUu6gM5YZQcvtLjayFmAPf6K818LfFvS73VbXQPFtlc+FfFk8zQx6ZfKzLLhiFeKfaEdWKkKcjcwIXPylvSqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDzX9o3T7rVfg34js7OLcxhFxJIWAWKOAidi3OTkRFQFBO51zhdzL6BpN39v0qzu91s32iFJd1rN50J3KDlJMDevPDYGRg4FVPFmkf8JB4V1nRvP+z/ANo2U1n52zf5fmIU3bcjOM5xkZ9a8f8Ah58RP+FfWGmeBvinDc6RqFlmys9WkizYXsSFBHslAGMI6AlhgBcuysSoAPdaq6t9u/sq9/sj7N/aXkv9l+1bvJ83adm/bzt3YzjnGcVaooA+S/i5D4z0rXdGl8TJpvh7VNZ1OOCTxf4euJLeGC2ZUja2m4Rmx5azbpXPCkKQFYL71pvwj8B2F3e3Q8M2N5c3j+ZPLqW6+d3ySWzOXIJLEkjGe+cCj4q+L/C+haNNp3iFLHVb68QfZNBkj8+S+l5MSeUFc4aRNocrtDY74FcJ4C8HfFeLwnY6Y/ie28JWVh5kdpA1vHqt40RkbalxIxEfyKFCeWACpwQuAAAdX+0LP/xbabTBdXNm2s3trpnn2w3yIssy78Rhg8uUDjy4wzMCRjbuI+cP2RPG76F49Ph6/v5Y9J1hGSGFmURC8G0o2WI2llVk+XlmKAg4BGr+0jq/jaLQH8M+PbKKeztbqC403XrC0ZIr1wkiFZsttSRlZ3Kr91oyApVw6+P3Wkadp3gjw/4p0HxHENbF00N5p4l8u6tZldnimixg+XsCfN/C/QkkhAD9JKKKKAMrxN4d0fxRpUmm+IdOttQsnyfLnQNtYqV3KeqsAxwykEZ4IrzWf4F6XpUz3fw717W/B96fKOy0uWntpWRywaaJzmThmG0vt56H5g3r9FAHkreH/jFpF3HLpnjXw/4ijdGSSHWdM+xpGcqVZDb5Zj94ckAehzkVLT4qeMtJuobPxn8LPECSG1WRrnQsagjyZwflX5UBwxwZGYfLwc5r2WuP8V2fjbVbqWz8P6npHh/TtmV1IxNe3bPlCAIWCRxj/WAktJkYwFPQA5r/AIX/APDqL93qGs3On3qfLPZ3WnXKzW8g+9G4EZAZTkEAkZB5NH/DQfww/wChm/8AJC6/+N1wEc/h34g6VrOreH/jH43stSs7Jb+7jmmMa2sSqC5NtCkYfaqkHyiRuIJJ3Dd618H9Yn17wv8AbW8X2Piy23mNL2DTTZSq4YlllTeRnBTA2J8uD824GgDKb49/DRbWO4PiiLy5HaMAWlwXBUKSSnl7gPmGCQAeQCdpxtaX8VvAWp2EV5beL9ESKTO1bm7S3kGCRzHIVZencDIwRwRXa1Un02xuJnmnsraWV/K3O8SszeU5eLJI52OSy/3SSRg0AYH/AAsfwP8A9Dl4b/8ABpB/8VWD4y+LWh+HrlI4b/Q7tDbrcMzatGjBWXcu1FDs25CGBA5DDGc10d34B8HXl1NdXnhPw/Pczu0kssunQu8jsclmYrkkkkkmreieE/Dmg3b3Wh6BpGm3LoY2ls7KOFyhIJUsqg4yAcewpSTa0djSlOMJXnHmXZ3/AEseLt8e9O16dbS11PTdFhM8cDXElyxLs+7bhmi+VBtO59uBxlk3A13XgfVPBGmXbC38Y6FqeuahIEaQalE8krseERd5PJxxkknHXAx6Hd20F5aTWt5DFPbTI0csUqBkkQjBVgeCCCQQa5r/AIVx4H/6E3w3/wCCuD/4moVNJ3buzpq42UoOlTioRe6V9fVttv7zQ8QeK9A8PR3ba1q9jZm1tfts0ckw8xYd2zf5Y+YgsQowDliFGSQK+T/jP8Wb74u38HgbwFplzLZTXo2yq7LJqG0fLlOAkQO5zvzwqMdm0ivqD/hXHgf/AKE3w3/4K4P/AImua0j4LaB4c1kaj4M1XxB4aYoElt9PvBJBMRvAaRJ1kDkByBngdQAea0OI7XwV4fg8K+EdI0K18po7C1jgMkcQiErgfPJtGcFmyx5PLHk9a2q4+78K681rMtn4/wDEEVyUYRSS2mnyIr44LKLZSwBxkBhn1HWvMJ/in8Q/BV+9t4w8Dalq+kQwxStq1paiGRIlB86WZYpJod3BO0SIMDJ2hhtAPf6K8w8F/HHwb4pu9Ps1nvtKvtRcpZW+p2xi+0jJUMjqWjILq6D5sllK4zjPp9ABRRRQAUUUUAFfJek+T8OvjbZaPpv2mS30zxAmmxKvmBXstThDpA0h3ALbyKXVGJ8xndwFIY19aV8q/tK+CtZ0PxwnxC0l/L0jzrK7v7xY4Jp7GeFlijaNH2llIZDsDEMwO/ACkAHYad420X4RfEvxpoHiueWx0nV7oeINPu2iacyPOAs6t5eSAJEIQFBwjZJyufeqitLmC8tIbqzmintpkWSKWJwySIRkMpHBBBBBFS0AZXibw7o/ijSpNN8Q6dbahZPk+XOgbaxUruU9VYBjhlIIzwRXj9zZfEv4UfarzS7m5+InhuSYO1ndvI2p2+7coCON25R+63EA85IRBuavYNd8R6H4f8j+3tZ03TPP3eV9tukh8zbjdt3EZxkZx0yK0LS5gvLSG6s5op7aZFkilicMkiEZDKRwQQQQRQBwngz4w+BvF3kx6Zr1tDeyeUos70/Z5vMk6RqHwJGzwQhYZxzyM+gVxXjXT/h9q+qxab4xi8NzaveQi3gjvmhW7eN2ZVERJEgyxbaVIO7OOa+RfizB4DsNZWfwBb32gx6S8kRuo52a6mvxtZE+zzzLPBHGVYGbbw5I2nAJAPu+ivgv4Z/Gj4h2PirR7OHU7nXknmitBp99KG+07nbC+a/KMWlOHz2QNlUCj70oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqpqum2Or2EtjqtlbX1lLjzLe5iWWN8EEZVgQcEA/UCrdFAHlX/DPnww/6Fn/AMn7r/45Utp8BPhna3cNxF4XiaSJ1kUS3dxIhIORuRpCrD1BBB6EGvUKKAOa0jwF4T0bWRq2k+G9IstRCCNZre0SMoBuHygDCkh2BIwWGASQAB0tFFAFTVdNsdXsJbHVbK2vrKXHmW9zEssb4IIyrAg4IB+oFeN61+zH8P8AUbtJrMavpUYQIYbO7DIxyTuJlV2zyBwccDjqT7fRQB41ongD4neFbV20f4kxa7IrmQWWvWLNFKSAp3TeY8qgD5gFONw6cmtD/i9//VNv/J6vVaKAPNdLT4wy38SarcfD+2sjnzJba3vJ5F4OMIzoDzgfeGBk84wan/CE/E//AKK5/wCW1a//ABVeq0UAeS3PhH4s2kYuNO+JtjqVzE6OtnfaFDbwTAMNyvJHudQRn7oz2yOo4Xx1o37Qz67Y6npupabLs37LTRZ0jt4cqqnzEuAvmZ5I3F9pyRt4r6UooA8Q8L+Nfizodrv+IPgCXULGJERrrRZYZLvOCCxgWRvMLMUzs2BRuOCOBtf8Lk/6px8Sf/BH/wDZ16rRQB5U/wAWdUvLaZdC+Gfjea/XZsj1GzWxhbdIicyszYxvzwpwAScKGYFz8R/GM01pBo3wr1ue4nhe6b7deQ2kaQ78RfvDuAlK8tE210PGGHzV6rRQB5V/wm3xP/6JH/5ctr/8TUy678WNYtZFsPBvh/w5cxup8zWdWN2kyENkItuuQQQvLMOvAPUen0UAeYW1n8WtRkNn4hb4drpNwjx3Pl2t3clkKkbfKd0VgehBYcE9eh4rxf8ABX4garqLa9a/E+WXxGlqtlFIlmdODQ+ZvKNJA5OMkt905IAPqPoSigDyCDxj458FWelab4k8BalrdlawxWk2saNff2hNcyCHmTyCiycsvzFyACTy3G7pdE+LPgnVLV5JfEFjpdzE5huLLVpVs7i3lAG6N45CDlSdpIyuQQCcGu6rF1vwn4c167S61zQNI1K5RBGst5ZRzOEBJChmUnGSTj3NAHnXxovPD/iHwabjW9K/t3wMkMl2NY0jVYVe2uULRAqruiv99guGfLjaYzxn56bz01+Pwp4F8X+KfBNtYWrTzx+MNYOnIrs6kRxxxLhSQ+/n724nAxlvp+5+Cnw9n1ldVTw5FaXyukiSWNzNaCN1xtZFidVQjAOVA55680WPwU+Htnd2dwvhyKdrNGjgjvLma6ijRixKiOV2TGXdsY+8xPXmgD5L1ma08TeEbXwnp/gGKXxro6RY1Hw08dylzDgB5JvIDiQ48oE7j87Mdyco32J8F73XL/4X+H5vFdtc22tLC0M6XSOkx8t2RXcP825lVWJPUsT0NbeieE/Dmg3b3Wh6BpGm3LoY2ls7KOFyhIJUsqg4yAcewraoAKKKKACiiigAr568V/B/x1q3j3xdr8fiWxuY9R0+fT9PjuJpYlSGbCGGVEQjy0jeUrgnMixuw5YV9C0UAfGuk/sxePNM1Wyv4NU8NmW1mSdB9sukyysGHzJGrL06qwI7EHmtDw9+ytrMWp2x13VtIlsZLWdbgQtMXhmZJFiZBtXzArGJzkpn5lwQMt9dUUAfOuhfs5/2P4q8LXhu9E1HTdLhMN7Feadn7dve5Z3aPcRuVZIEUsx+7u/gCN6rqnwp8BanYS2dz4Q0RIpMbmtrRLeQYIPEkYVl6diMjIPBNdrRQB5V/wAKA+HUX7zT9GudPvU+aC8tdRuVmt5B92RCZCAynBBIIyBwaq6F+zz4G0/VZ9S1OPUvEF7LMtwZNXuvN/eBixLBAok3E/MHDA49zn1+igCppWm2OkWEVjpVlbWNlFny7e2iWKNMkk4VQAMkk/UmrdFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The posterior pelvic tilt is a basic maneuver in back rehabilitation. The abdominal and gluteal muscles are contracted to flatten the lumbar spine. This position is held for 5 to 10 seconds and can be repeated frequently.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Sheon, RP, Moskowitz, RW, Goldberg, VM. Soft Tissue Rheumatic Pain: Recognition, Management, Prevention, 3rd ed, Williams &amp; Wilkins, Baltimore 1996.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35054=[""].join("\n");
var outline_f34_14_35054=null;
var title_f34_14_35055="Lip laceration through the vermillion border";
var content_f34_14_35055=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F55006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F55006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 480px\">",
"   <div class=\"ttl\">",
"    Lip laceration through the vermillion border",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 460px; height: 484px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The edges of the vermillion border must be precisely aligned to achieve an optimal cosmetic outcome for lacerations that cross the vermillion border. To accomplish this, the first suture placed should bring the edges of the vermillion border together.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_14_35055=[""].join("\n");
var outline_f34_14_35055=null;
